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Kuvailulehti
Julkaisija Elintarviketurvallisuusvirasto Evira
Julkaisun nimi Suomalaisten 1-, 3- ja 6-vuotiaiden lasten A-vitamiinin saanti maksaruokien 
välityksellä - kvantitatiivinen riskinarvointi
Tekijät Kirsi-Helena Liukkonen, Tapani Lyytikäinen, Tero Hirvonen, 
Christina Bäckman, Carina Kronberg-Kippilä, Suvi Virtanen
Tiivistelmä Maksa sisältää runsaasti A-vitamiinia ja monia muita ravintoaineita. Vaikka 
maksa on monipuolinen ruoka-aine, sen käytössä on myös haittansa. A-vi-
tamiini esiintyy maksassa retinoidimuodossa, mikä voi jatkuvina suurina an-
noksina aiheuttaa myrkytyksen. 
Liiallisen A-vitamiinin saannin ehkäisemiseksi maksaruokia ei vuodesta 
1990 lähtien ole suositeltu alle 1-vuotiaille. Leikki-ikäisten lasten maksa-
ruokien (jauhemaksa- ja maksapihvi, maksakastike, maksalaatikko), mak-
samakkaran ja –pasteijan käyttöä on neuvottu rajoittamaan pariin kertaan 
kuukaudessa. Suositusten tarpeellisuuden arvioimiseksi Elintarviketurval-
lisuusvirasto Evirassa tehtiin riskinarviointi suomalaislasten A-vitamiinin 
saannista maksaruokien välityksellä. Riskinarvioinnin tavoitteena oli arvi-
oida 1-, 3- ja 6-vuotiaiden  lasten altistumista maksaruokien retinoidimuo-
toiselle A-vitamiinille sekä samalla selvittää, tuleeko lasten maksaruokien 
käyttöä edelleen rajoittaa. 
Riskinarvioinnissa käytettiin maksaruokien kulutustietoja (DIPP-ravintotut-
kimus) sekä resepti- ja retinoidipitoisuustietoja. Monte Carlo -simulaatiolla 
arvioitiin A-vitamiinin ja retinoidien saantia maksaruoista sekä ilman mak-
saruokien käyttöä. Altistusta arvioitiin pitkäaikaissaantina sekä altistuksena 
kerta-annoksesta. Simulointituloksia verrattiin saantisuosituksiin ja saannin 
ylärajoihin. Simulointimallin avulla arvioitiin myös  maksaruokien turvallista 
annoskokoa ja syöntitiheyttä. 
Riskinarvioinnissa tehtiin seuraavat johtopäätökset:
1. Vaikka maksansyönti auttaa joitain lapsia A-vitamiinin saantisuositusten 
täyttymisessä, se voi  altistaa toisia lapsia liian suurille retinoidipitoisuuk-
sille.
2. Todellisten maksansyöjien osuus on hyvin todennäköisesti suurempi kuin 
kolmen päivän ruoankäyttötietojen perusteella voidaan olettaa.
3. Tarkasteltaessa maksaruokien pitkäaikaiskäytön turvallisuutta todetaan, 
että annoskoon lisäksi syöntitiheydellä on keskeinen merkitys. Yksivuotias 
voi turvallisesti syödä maksamakkaraa tai –pasteijaa ja kolme- ja kuusivuo-
tias kaikkia maksaruokia, kunhan syöntitiheys ei ole liian suuri. Turvallinen 
annoskoko ja syöntitiheys riippuvat lapsen iästä ja maksaruuasta. Yleisesti 
maksamakkaraa ja –pasteijaa voi käyttää useammin kuin maksalaatikkoa, 
maksakastiketta tai maksapihvejä.
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Beskrivning
Utgivare Livmedelssäkerhetsverket Evira
Publikationens titel Intag av A-vitamin via maträtter som innehåller lever hos finska 1-, 3- och 
6-åriga barn – en kvantitativ riskbedömning
Författare Kirsi-Helena Liukkonen, Tapani Lyytikäinen, Tero Hirvonen, 
Christina Bäckman, Carina Kronberg-Kippilä, Suvi Virtanen
Resumé Lever innehåller rikligt med A-vitamin och flera andra näringsämnen. Även 
om lever är ett mångsidigt födoämne finns det också nackdelar med att äta 
lever. A-vitamin förekommer i lever i form av retinoider som kan orsaka för-
giftning genom kontinuerligt högt intag. 
För att undvika ett för högt intag av A-vitamin har leverrätter inte rekom-
menderats till barn under 1 år sedan 1990. Det har rekommenderats att 
konsumtionen av leverrätter (biff på mald lever och leverbiff, leversås och 
leverlåda), leverkorv och –pastej hos barn i lekåldern begränsas till ett par 
gånger i månaden. För att bedöma nödvändigheten av rekommendatio-
nerna har Livsmedelssäkerhetsverket Evira gjort en riskbedömning av fin-
ländska barns intag av A-vitamin från leverrätter. Målsättningen med risk-
bedömningen var att bedöma hur 1-, 3- och 6-åriga barn exponeras för 
A-vitamin i form av retinoider från leverrätter och att bedöma om barnens 
intag av leverrätter fortfarande skall begränsas. 
Vid riskbedömningen användes uppgifter om konsumtion av leverrätter 
(DIPP-nutritionsundersökning) samt receptinformation och uppgifter om re-
tinoidnivåer. Intaget av A-vitamin och retinoider från leverrätter och även 
intag utan konsumtion av leverrätter bedömdes med hjälp av Monte Carlo-
simulering. Exponeringen bedömdes som långtidsintag och som expone-
ring från en engångsdos. Simuleringsresultaten jämfördes med rekommen-
dationerna för intag och med de övre gränserna för intaget. Med hjälp av 
simuleringsmodellen beräknades också en trygg portionsstorlek och kon-
sumtionsfrekvens. 
Utgående från riskbedömningen drogs följande slutsatser:
1. Även om konsumtion av lever hjälper vissa barn att uppnå rekommenda-
tionerna för intag av A-vitamin, så kan andra barn utsättas för alltför höga 
halter av retinoider.
2. Andelen verkliga leverkonsumenter är mycket sannolikt högre än vad 
som kan antas utgående från uppgifterna om tre dagars matkonsumtion.
3. Vid granskningen av säkerheten i långtidsintag av leverrätter är förutom 
portionens storlek också konsumtionsfrekvensen av central betydelse. En 
ettåring kan tryggt äta leverkorv eller –pastej och en treåring och en sex-
åring alla leverrätter, bara konsumtionsfrekvensen inte är för hög. Barnets 
ålder och leverrätten ifråga är avgörande för bedömningen av en trygg por-
tionsstorlek och konsumtionsfrekvens. I allmänhet kan leverkorv och –pastej 
konsumeras oftare än leverlåda, leversås eller leverbiffar. 
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Definitions and abbreviations
Bioavailability
The fraction of the ingested dose of a compound that is available to mediate biological effects in the 
body.
CAC
Codex Alimentarius Commission
Carotenoids
Organic pigments naturally occurring in photosynthetic organisms. Some carotenoids are vitamin A 
precursors (provitamin A carotenoids). 
Chylomicron
Large lipoprotein molecules that are created by the absorptive cells of the small intestine. Chylomicrons 
transport absorbed lipids to target tissues.  
Food supplement
Foodstuffs the purpose of which is to supplement the normal diet, and which are concentrated sources 
of nutrients or other substances with a nutritional or physiological effect, alone or in combination, 
marketed in dose form, namely forms such as capsules, pastilles, tablets, pills and other similar forms, 
sachets of powder, ampoules of liquids, drop dispensing bottles, and other similar forms of liquids and 
powders designed to be taken in measured small unit quantities.
DIPP 
The Finnish Type I Diabetes Prediction and Prevention study
EAR
Estimated average requirement. Nutrient intake value estimated to meet the average physiological 
requirement of the selected population group.
FAO
Food and Agriculture Organization of the United Nations
FNB
Food and Nutrition Board. Unit of the Institute of Medicine, part of the National Academy of Sciences, 
USA
IU
A unit of measurement for the amount of a substance, based on measured biological activity. For vitamin 
A, 1 IU equals the biological activity of 0.3 µg retinol (0.3 µg RE).
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LOAEL
Lowest-observed-adverse-effect level
MAVIRA
Short for “Intake of vitamin A, cadmium and lead via liver foods among Finnish women of fertile age” 
– project.
NCM
Nordic Council of Ministers
NOAEL
No-observed-adverse-effect level
RBP
Retinol-binding protein
RAE
Retinol activity equivalent → Retinol equivalent
RE
→ Retinol equivalent
Retinoids
A class of chemical compounds consisting of a six-carbon ring structure with a polyprenoid side chain 
and a terminating carbon-oxygen functional group. In this risk assessment, the term refers to natural and 
synthetic retinoid derivatives with the biological activity of retinol.  
Retinol equivalent
The specific biological activity of 1.0 microgram of all-trans retinol
Retinol
The most common natural retinoid (as free retinol or esterified to fatty acids), and the key molecule in 
body retinoid metabolism
RDI, RDA
Recommended dietary intake, recommended dietary allowance. The nutrient intake over time that 
theoretically would fulfil the needs of practically all (97.5 %) healthy individuals in a selected population 
group. RDI or RDA is calculated by adding a safety margin equal to two standard deviations to the 
estimated average requirement (EAR).
SCF
Scientific Committee on Food, European Commission
STRIP
Special Turku Coronary Risk Factor Intervention Project
UL
Upper tolerable level. The maximum daily intake of a nutrient unlikely to pose a risk of adverse health 
effects to humans.
US
United States
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WHO
World Health Organisation of the United Nations
VAD
Vitamin A deficiency
Vitamin A
Retinoids and provitamin A carotenoids that exhibit the biological activity of retinol
VRN
National Nutrition Council, Valtion ravitsemusneuvottelukunta
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Yhteenveto
A-vitamiini
A-vitamiini on välttämätön luonnossa esiintyvä 
rasvaliukoinen ravintoaine, jolla on tärkeä merki-
tys monissa biologisissa toiminnoissa, kuten nä-
kökyky, solujen kasvu ja erilaistuminen, elimis-
tön puolustusmekanismit ja sikiönkehitys. Sekä 
A-vitamiinin puute että liiallinen saanti voivat ai-
heuttaa terveyshaittoja. A-vitamiinin puute on 
harvinaista länsimaissa, mutta retinoidimuotoi-
sen A-vitamiinin liikasaannin riski on olemassa. 
Sen sijaan karotenoidien liikasaannin ei ole osoi-
tettu aiheuttavan A-vitamiinimyrkytystä. 
Ihmiselimistö ei pysty itse valmistamaan A-vi-
tamiinia, vaan se on saatava ravinnosta. Ravin-
nossa A-vitamiini esiintyy kahdessa muodos-
sa: retinoideina eläinperäisissä ruoka-aineissa 
ja A-vitamiinin esiasteina karotenoideina kasvi-
kunnan tuotteissa. Maksan retinoidipitoisuus on 
korkeampi kuin minkään muun ruoka-aineen. 
Retinoideja esiintyy myös ravintorasvoissa, ras-
vaisissa maitovalmisteissa, rasvaisissa kaloissa ja 
kananmunissa. Karotenoideja on vihreissä lehtivi-
hanneksissa, keltaisissa kasviksissa ja keltaisissa 
ja oransseissa ei-sitrushedelmissä. Vitaminoidut 
elintarvikkeet ja ravintolisät voivat myös sisältää 
retinoidi- tai karotenoidimuotoista A-vitamiinia. 
Luonnollisten A-vitamiinilähteiden nauttiminen 
aiheuttaa harvoin myrkytystä. Poikkeuksena on 
liiallinen maksan, vitaminoitujen elintarvikkei-
den ja ravintolisien jatkuva käyttö. 
Projektin historia ja tavoitteet
Vuonna 1989 havaittiin suomalaisen sianmaksan 
sisältävän erittäin korkeita A-vitamiinipitoisuuk-
sia. Retinoidien mahdollisten haittojen vuoksi on 
vuodesta 1990 lähtien raskaana olevia ja lapsia 
neuvottu rajoittamaan maksaruokien käyttöä. Vä-
hentämällä A-vitamiinin käyttöä eläinten rehuis-
sa ja terveydenhoidossa sianmaksan A-vitamii-
nipitoisuudet saatiin kuitenkin pian laskemaan. 
Raskaana oleville ja lapsille annettuja maksan 
käyttösuosituksia ei kuitenkaan muutettu. 
Elintarviketurvallisuusvirastossa valmistui vuon-
na 2007 riskinarviointi hedelmällisessä iässä ole-
vien suomalaisnaisten altistumisesta A-vitamii-
nille maksaruokien välityksellä (Mavira-projekti, 
Lavikainen ym. 2007). Riskinarviointiin perustu-
en viranomaiset päättivät lieventää maksan ras-
kaudenaikaista käyttöä koskevia suosituksia. Ris-
kinarviointi vahvisti, että pääruokina syötävien 
maksaruokien käyttöä raskauden aikana tulee 
edelleen välttää, mutta kohtuullinen maksamak-
karan ja –pasteijan käyttö on kuitenkin turvallis-
ta.
Tämän riskinarvioinnin tavoitteena on arvioida 
1-, 3- ja 6-vuotiaiden suomalaislasten retinoidien 
saantia maksaruokien välityksellä sekä samalla 
selvittää, onko maksaruokien käytön rajoittami-
nen lapsilla edelleen tarpeen. 
Altistuksen arviointi
A-vitamiinin ja retinoidien saannin arvioimisek-
si saatiin pitkäaikaisesta tyypin 1 diabeteksen 
ennustamis- ja ehkäisytutkimuksen (DIPP-tut-
kimus) ravintotutkimuksesta 963 yksivuotiaan, 
835 kolmevuotiaan ja 850 kuusivuotiaan ruo-
ankäyttötiedot.  Lisäksi käytettiin sian-, naudan- 
ja broilerinmaksojen laboratorioanalyysejä sekä 
elintarviketeollisuudelta ja Kansanterveyslaitok-
selta saatuja resepti- ja markkinaosuustietoja.
Kerätyn tiedon perusteella rakennettiin Monte 
Carlo –simulaatiomalleja, joiden avulla arvioitiin 
lasten A-vitamiinin ja retinoidien saantia mak-
saruokien välityksellä ja ilman maksaruokia. Tu-
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loksia verrattiin A-vitamiinin saantisuosituksiin 
ja retinoidien saantirajoihin. Malleja sovellettiin 
myös turvallisen maksaruokien annoskoon ja 
syöntitiheyden arviointiin. 
Maksaruokien retinoidit
Retinoidien keskimääräinen pitoisuus oli korkein 
maksapihveissä (82 µg RE/g, vaihteluväli 15-
806 RE/g). Seuraavina tulivat laskevassa järjes-
tyksessä maksakastike (54 µg RE/g, vaihteluvä-
li 12-474 RE/g), maksamakkara tai -pasteija (26 
µg RE/g, vaihteluväli 8-59 µg RE/g) ja maksa-
laatikko (15 µg RE/g, vaihteluväli 10-41 µg RE/
g). Retinoidipitoisuuksien vaihteluvälit  heijaste-
livat vaihtelua sekä raaka-ainemaksojen retinoi-
dipitoisuuksissa  että reseptien koostumuksessa 
(maksan osuus). 
A-vitamiinin ja retinoidien saanti 
Noin 1 % yksivuotiaista ja 18 % kolme- ja kuusi-
vuotiaista oli syönyt maksaruokia kolmen tutki-
muspäivän aikana. Useimmin syöty maksaruoka 
oli maksamakkara tai –pasteija. Seuraavana tuli 
maksalaatikko. Vain muutamat lapset olivat syö-
neet maksakastiketta tai –pihvejä. 
Maksan merkitys A-vitamiinin lähteenä oli il-
meinen, sillä maksansyöjillä keskimäärin 54-57 
% retinoidien saannista ja 39-48 % A-vitamiinin 
saannista tulivat maksaruuista. Kaikilla maksan-
syöjillä keskimääräinen A-vitamiinin tarve (210 
µg RE/päivä 1- ja 3-vuotiailla ja 275 µg RE/päivä 
6-vuotiailla) täyttyi. Sen sijaan maksaa syömät-    
tömistä 1-vuotiaista 41 %:lla ja 3- ja 6-vuotiaista 
10 %:lla A-vitamiinin saanti jäi alle keskimääräi-
sen tarpeen. 
Todelliset maksansyöjät 
Kulutustietojen heikkoutena oli se, että ne eivät 
sisältäneet tietoa todellisten maksansyöjien ja 
maksaa syömättömien osuudesta. On hyvin to-
dennäköistä, että osa vastaajista ei vain sattu-
nut syömään maksaruokia niiden kolmen päivän 
aikana, jolloin ruokapäiväkirjat täytettiin. Tällöin 
todellinen maksaa syövien osuus tutkimusjou-
kossa olisi suurempi. 
Kun todellisten maksansyöjien syöntitiheyttä ja 
osuutta arvioitiin zero-inflated Poisson -regres-
siolla, hieman yli 20 % DIPP-ravintotutkimuk-
sen 3- ja 6-vuotiaista arvioitiin olevan todelli-
sia maksamakkaran tai –pasteijan syöjiä ja noin 
40 % todellisia maksalaatikon syöjiä. Maksamak-
karan tai –pasteijan todelliseksi syöntitiheydek-
si todellisten maksansyöjien keskuudessa arvioi-
tiin joka neljäs tai viides päivä  ja maksalaatikon 
joka toinen viikko. Nämä arviot osoittavat, että 
todellisten maksansyöjien osuus on hyvin toden-
näköisesti suurempi, mutta syöntitiheys pienem-
pi kuin mitä voitiin suoraan kolmen päivän ha-
vainnoista arvioida.
Retinoidien kerta-annos- ja pitkäaikaissaanti
Retinoidien saanti maksaruoan kerta-annoksesta 
jäi alle turvatason 30 000 µg RE, mikä osoittaa 
sen, että yksittäiset annokset maksaruokia hyvin 
todennäköisesti eivät altista lapsia haitallisille 
tasoille retinoideja.  
Sen sijaan maksan pitkäaikainen käyttö voi al-
tistaa lapset suuremmille retinoidipitoisuuksil-
le kuin mitä voidaan pitää turvallisena. Kun re-
tinoidien saantia verrattiin saannin turvallisiin 
ylärajoihin (800 µg RE/päivä 1- ja 3-vuotiaat ja 1 
100 µg RE/päivä 6-vuotiaat), 15 % yksivuotiais-
ta,  34 % kolmevuotiaista ja 28 % kuusivuotiaista 
ylittivät suositellun ylärajan. Maksaa syömättö-
millä ei ollut vaaraa ylittää suurinta saantirajaa. 
Syöntitiheyden vaikutus pitkäaikaiseen 
saantiin
Tämä riskinarviointi osoittaa, että maksaa syövil-
lä lapsilla retinoidien saanti voi ylittää siedettä-
vän ylärajan. Suurin riski liittyy maksakastikkeen 
ja –pihvien käyttöön. Seuraavina tulevat maksa-
laatikko sekä maksamakkara- ja pasteija. Mak-
saruokia voi kuitenkin sisällyttää 1–6-vuotiaiden 
ruokavalioon, kunhan niitä ei syödä liian usein. 
Annoskoon ohella syöntitiheys on keskeinen te-
kijä maksaruokien turvallisessa pitkäaikaiskäy-
tössä.
Yleisesti maksamakkaraa tai –pasteijaa voi syö-
dä useammin kuin pääruokana syötäviä maksa-
ruokia (maksalaatikkoa, maksapihvejä tai mak-
sakastiketta). Ikäryhmästä riippumatta (1-, 3- ja 
6-vuotiaat) turvarajoja ei todennäköisesti ylite-
tä, jos maksamakkaraa tai –pasteijaa syödään 
kohtuullisina annoksina kerran viikossa. Samaan 
aikaan voidaan syödä vain yhtä maksapääruo-
kaa, mutta harvemmin kuin maksamakkaraa tai 
–pasteijaa. Tällöin maksaa sisältävän pääruoan 
turvallinen syöntitiheys vaihtelee kuukaudesta 
kahteen kuukauteen riippuen ruuasta ja ikäryh-
mästä.
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Summary
Vitamin A 
Vitamin A is an essential, naturally occurring, 
fat-soluble nutrient that is involved in several 
important biological processes such as vision, 
cell growth and diversification, the defence 
mechanisms of the body, and foetal development. 
Both deficient and excessive intake of vitamin 
A may cause health problems. Vitamin A 
deficiency is rare in the Western world but the 
risk of excessive intake of vitamin A in retinoid 
form exists. On the other hand, overconsumption 
of carotenoids has not been shown to result in 
hypervitaminosis.
The body is not capable of producing vitamin A 
by itself which means that it has to be provided 
from the diet. In foods, vitamin A is derived 
from two sources: retinoids from foods of animal 
origin and provitamin A carotenoids mainly from 
plant-derived foods. Liver has higher retinoid 
content than any other food. Retinoids are also 
present in dietary fats, fatty milk products, fatty 
fish and eggs. Carotenoids are found in green 
leafy vegetables, yellow vegetables, and yellow 
and orange non-citrus fruits. In addition to foods, 
fortified foods and food supplements can contain 
vitamin A in the form of retinoids or carotenoids. 
Consuming natural sources of vitamin A rarely 
results in toxicity. The exception is toxicity 
resulting from excessively high intakes of liver or 
use of fortified foods and food supplements on a 
continued basis.
Project history and objectives
At the turn of 1989, very high concentrations 
of vitamin A (retinoids) in livers of pigs were 
reported in Finland (Heinonen 1990). Due to 
the possible risk of retinoids, pregnant women 
and children have been advised to restrict the 
consumption of liver-based foods since 1990. 
The vitamin A level in pig livers was, however, 
soon lowered by reducing the use of vitamin A 
in animal feeds and healthcare. Despite reduced 
retinoid content in livers, the recommendations 
on liver consumption for pregnant women and 
children remained unchanged. 
A risk assessment on the exposure of Finnish 
women of fertile age to vitamin A from liver-based 
foods was completed by the Finnish Food Safety 
Authority in 2007 (Mavira –project; Lavikainen 
et al. 2007). Based on the risk assessment, 
the authorities made the decision to ease the 
recommendations concerning the consumption of 
liver. The risk assessment confirmed that during 
pregnancy the consumption of liver dishes as the 
main course should still be avoided. Moderate 
consumption of liver sausage or liver pâté is safe, 
however. 
The objectives of this risk assessment were to 
estimate retinoid exposure from liver products 
among Finnish 1-, 3- and 6-year-old children 
and to assess whether the restriction of the 
consumption of liver-based foods by children is 
still necessary.
Exposure assessment
For estimating vitamin A and retinoid intake, 
consumption data of 963 one-year-olds, 835 
three-year-olds and 850 six-year-olds were 
obtained from the Finnish Type I Diabetes 
Prediction and Prevention (DIPP) Nutrition Study. 
In addition, laboratory analyses of swine (n=91), 
bovine (n=76) and chicken (n=270) liver samples, 
and market shares and recipe information from 
the industry and the National Public Health 
Institute of Finland were used. 
Based on the collected data, Monte Carlo 
simulation models were built to estimate 
children’s vitamin A and retinoid intake whether 
liver foods are eaten or not. Results were 
compared with the intake recommendations for 
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vitamin A and with the intake limits for retinoids. 
The models were also applied to estimate safe 
portion sizes and eating frequency of liver foods.
Retinoids in liver foods
The estimated mean retinoid content was the 
highest in liver patties (82 µg RE/g, range 15-
806 RE/g) followed in descending order by liver 
sauce (54 µg RE/g, range 12-474 RE/g), liver 
sausage or pâté (26 µg RE/g, range 8-59 µg RE/
g) and liver casserole (15 µg RE/g, range 10-
41 µg RE/g). The retinoid content varied within 
the liver food groups reflecting variation both 
in the retinoid content of the livers used as an 
ingredient and in the recipes (amount of liver) 
of liver foods. 
Intake of vitamin A and retinoids among 
liver and non-liver eaters
About 1% of 1-year-olds and 18% of 3- and 6-
year-olds had eaten liver foods during a 3-day 
food recording period. The most commonly eaten 
liver food was liver sausage or pâté followed by 
liver casserole. Only a few children ate liver sauce 
or liver patties. 
The importance of liver as a vitamin A source 
was clear because among liver eaters, an 
average 54-57% of retinoid intake and 39-48% 
of total vitamin A intake came from liver foods. 
All liver eaters achieved the average vitamin A 
requirement of 210 µg RE/day for 1- and 3-year-
olds and 275 µg RE/day for 6-years-olds whereas 
a whole 41% of 1-year-old and about 10% of 3- 
and 6-year-old non-liver eaters had an intake 
below the estimated average requirement. 
True liver eaters
The weakness of the consumption data was 
that it didn’t include information about the 
proportions of true liver and non-liver eaters. 
It is very likely that the real proportion of liver 
eaters among the study population was higher 
and part of responders just didn’t happen to eat 
liver products during those 3 days they filled in 
the food record.
When eating frequency and proportion of true 
liver eaters were estimated by zero-inflated 
Poisson regression, slightly over 20% of 3- and 
6-year-old DIPP Nutrition Study children were 
estimated to be true liver sausage or pâté eaters, 
and about 40% true liver casserole eaters. True 
eating frequencies were estimated to be every 
fourth or fifth day and every second week for liver 
sausage or pâté and liver casserole, respectively. 
These estimates indicate that in real populations 
the proportion of true liver eaters is very probably 
much higher, but eating frequency among true 
eaters is lower than could be estimated directly 
according to 3-day observations. 
Single meal and long term intakes of 
retinoids
The amount of vitamin A obtained from liver-
based retinoids, remained below the specified 
safe level of  30 000 µg RE from a single portion 
indicating that moderate single portions of liver 
foods probably do not  expose children to harmful 
doses of retinoids. 
Instead, long term liver consumption may expose 
children to retinoid intakes higher than what 
is considered safe. When the retinoid intake 
estimates were compared with upper tolerable 
daily intake levels for children (800 µg RE/day 
for 1- and 3-year-olds and 1 100 µg RE/day for 
6-year-olds), 15%, 34% and 28% of 1-, 3- and 6-
year-old liver eaters, respectively, exceeded the 
recommended upper intake limit. Among non-
liver eaters, there was no risk of exceeding the 
maximum intake limit. 
Effect of eating frequency on long term 
retinoid intake
This risk assessment indicated that among liver 
eaters, dietary retinoid intakes may exceed the 
tolerable upper levels for children. The highest 
risk is related to the consumption of liver sauce 
or patties followed in descending order by liver 
casserole and liver sausage or pâté. Liver foods 
can, however, be included in the diet of 1-6-
year-old children as long as they are not eaten 
too often. In addition to portion size, eating 
frequency is an important factor in safe long 
term consumption of liver foods. 
In general, liver sausage or pâté can be 
eaten more often than liver main courses 
(liver casserole, liver sauce and liver patties). 
Independent of age group (1-, 3- or 6-year-olds), 
safety thresholds are not likely to be exceeded 
if liver sausage or pâté is eaten in moderate 
amounts once a week. At the same time, only 
one of the liver main courses can be eaten but 
more seldom than liver sausage or pâté: the safe 
eating frequency varied from once a month to 
once every two months depending on the liver 
main course and age group.
Intake of vitamin A from liver foods among Finnish 1-, 3-and 6-year-old children – a quantitative risk assessment
18
1. Introduction
Risk assessment
1.1 Vitamin A
Vitamin A is an essential nutrient that plays a very 
important role in many biological processes. It 
can not be synthesised de novo within the body, 
and has to be provided from the diet. Vitamin A 
in foods is derived from two sources: retinoids 
from foods of animal origin and provitamin A 
carotenoids mainly from plant-derived foods. 
The retinoid content of liver is several times 
higher than in any other foodstuffs (KTL 2005). 
In addition to intake from foods, vitamin A can 
be taken as food supplements in the form of 
retinoids or carotenoids. 
1.2 Project history 
At the turn of 1989, very high concentrations 
of vitamin A in livers of pigs were reported in 
Finland (Heinonen 1990). Consequently the 
authorities gave recommendations to decrease 
the use of liver foods (Julkunen et al. 1990). 
By changing the composition of animal feeds 
and cutting down on the overuse of additional 
vitamin preparations, the vitamin A level in pig 
livers was soon lowered. Despite reduced vitamin 
A content in livers, the recommendations for liver 
consumption by pregnant women and children 
remained unchanged. In order to prevent 
excessive intake of vitamin A, liver-based foods 
have not been recommended since 1990 for 
children under the age of one year. For toddlers, 
it has been advised to restrict the consumption 
of liver-based foods (ground liver patties, liver 
steak, liver stew, and liver casserole), liver 
sausage and liver pâté to a couple of meals per 
month (Hasunen et al. 2004). 
The Finnish Food Safety Authority published in 
August 2007 a risk assessment on the exposure 
of Finnish women of fertile age to vitamin A 
(Mavira –project; Lavikainen et al. 2007). Based 
on the risk assessment, the authorities eased the 
recommendations concerning the consumption 
of liver. The risk assessment confirmed that 
consumption of liver-based foods during 
pregnancy should still be restricted because the 
amount of vitamin A obtained from a liver-based 
meal may considerably exceed the safe intake 
limit from a single portion. Moderate consumption 
of liver sausage or liver pâté, however, will not 
result in the limit being exceeded. 
This risk assessment started in September 2007 
and is a continuation of the risk assessment of 
retinoid intake from liver foods among Finnish 
women of fertile age, and it evaluates whether 
the restriction of children’s consumption of liver-
based foods is still necessary. 
 
1.3 Objectives 
The objectives of this research were
To estimate retinoid intake from liver 
products among Finnish 1-, 3- and 6-year-
old children.
To assess the risk of intolerably high retinoid 
intake if recommendations for consumption 
would be removed or whether they would 
be loosened.
1.
2.
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1.4 Parts of risk assessment
This risk assessment follows the format of the 
Codex Alimentarius Commission (CAC 2004) and 
consists of four parts: hazard identification, hazard 
characterisation, exposure assessment and risk 
characterisation. They are described below:
Hazard identification: Describes the 
general properties of vitamin A, such 
as chemistry, sources and metabolism, 
bioavailability and physiological functions. 
Hazard identification includes the current 
intake recommendations.
Hazard characterisation: Describes the 
toxicological properties of vitamin A. 
The common symptoms occurring due 
to excessive or insufficient intakes are 
characterised. The toxicity to children is 
described, and recommended safety limits 
are discussed. 
1.
2.
Exposure assessment: Evaluates the 
exposure to retinoids from liver foods among 
Finnish 1-, 3- and 6-year-old children. This 
part consists of two subsections: 1) The 
consumption of food products containing 
liver is estimated based on data obtained 
from the DIPP Nutrition Study and 2) The 
intake of retinoids from liver products 
is then estimated by using a simulation 
model constructed for this study. Recipes 
of liver foods and retinoid contents of livers 
are obtained from the MAVIRA-project. 
As the importing of liver into Finland is 
very marginal, it is not included in the 
assessment.
Risk characterisation: This step brings 
together the preceding three sections. The 
effects of liver consumption on intake of 
total vitamin A and retinoids are studied. 
Results are compared with the intake 
recommendations and safety levels for 
children. The models are also applied to 
estimate safe combinations of portion size 
and eating frequency for liver foods and 
their combinations.
3.
4.
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2. Hazard identification of vitamin A
2.1 Chemical structure and 
definitions 
Vitamin A is the generic name for retinoids 
(retinol, retinyl, retinal and retinoic acid) and 
carotenoids which have retinol (IUPAC-IUB 1981) 
activity. It is an essential nutrient that plays a very 
important role in a large number of physiological 
functions. 
Generally, the  structure of retinoids consists of a 
six-carbon β-ionone ring, a conjugated isoprenoid 
side chain, and a polar terminal group with an 
oxidation state that may vary: a hydroxyl group in 
retinols, an aldehyde in retinals, and a carboxylic 
moiety in retinoic acids (Figure 1). Differences 
in the functional group and alterations in the 
molecular skeleton give about 600 different 
retinoid analogues with different chemical 
properties and potentially different biological 
activities (Gundersen & Blomhoff 2001). 
The term vitamin A includes retinol and provitamin 
carotenoids that are dietary precursors of vitamin 
A and can be converted to retinol in the body. 
Provitamin A carotenoids are less biologically 
active than retinol. They are derived from a 40-
carbon polyene chain, which is terminated by one 
or two cyclic end-products (Sklan 1987) (Figure 
2). About 50  of the 600 carotenoids found in 
nature, can be converted into retinol. Carotenoids 
with provitamin A activity are β-carotene, 
α-carotene, γ-carotene and β-cryptoxanthin. β-
Carotene is the most important of the provitamin 
carotenoids in terms of its relative provitamin A 
activity and quantitative contribution to the diet 
(Underwood 1984; Bendich & Langseth 1989). 
The vitamin A activity is expressed in terms of 
‘retinol equivalent’ (RE), where 
1 µg RE = 1 µg retinol = 1.78 µg retinyl palmitate 
= 12 µg β-carotene = 24 µg other carotenoids 
with provitamin A activity = 3.33 IU vitamin A 
activity from retinol (FNB 2001; EVM 2003).
In this assessment, the term vitamin A refers to 
the total amount of vitamin present in the diet, 
including retinoids and provitamin A carotenoids. 
The term retinoids is used to group retinol and its 
natural and synthetic derivatives that have the 
biological activity of retinol.
2.2 Dietary sources
Vitamin A cannot be synthesised de novo by the 
human body, and has to be provided from the 
diet. Vitamin A is found naturally in many foods 
(Table 1). It occurs mainly as retinoids in foods 
of animal origin and in the form of provitamin 
A carotenoids in plant foods. In addition to 
foods, fortified foods and food supplements can 
contain vitamin A in the form of retinoids or 
carotenoids. 
Liver has a higher retinoid content than any 
other food. Retinoids are also present in dietary 
fats, fatty milk products, fatty fish and eggs. 
Carotenoids are found in green leafy vegetables, 
yellow vegetables, and yellow and orange non-
citrus fruits (Booth et al. 1992).
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Figure 2. Chemical structure of β-carotene
Table 1. Mean vitamin A content of some Finnish foods (KTL 2005). 
Food Mean vitamin A 
content  
(µg RE/ 100 g)
Food Mean vitamin A 
content  
(µg RE/ 100 g)
In retinoid form In carotenoid form
Liver (average) 18 000 Rose hip puree 1 230
Margarine, fat spread 850 Carrot 774
Butter 706 Sweet potato 767
Fatty fish (average) 648 Borecole 766
Infant formula 519 Pumpkin 367
Cream, fatty 334 Spinach 275
Egg 260 Red paprika 243
Cheese (average) 231 Celery 243
Fish (average) 67 Broccoli 85
Beef burger (pig-bovine) 61 Leek 83
Chicken 37 Lettuce 82
Beef steak 5 Tomato 66
Pea 31
Orange 10
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 Figure 1. Chemical structures of some natural retinoids.
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2.3 Metabolism
2.3.1 Absorption
In foods, retinoids occur mainly as retinyl esters. 
After ingestion, retinyl esters are completely 
hydrolysed in the intestinal lumen (Harrison 
2005). Free retinol is then taken up by intestinal 
cells, bound to a specific cellular retinol-binding 
protein (RBP) and re-esterified with long chain, 
mainly saturated, fatty acids. The resulting 
retinyl esters are incorporated with other 
neutral lipid esters into large lipoproteins called 
Chylomicrons. 
Provitamin A carotenoids are either cleaved to 
generate retinol or are absorbed intact. In the 
former case, that is the major pathway, the 
molecules are cleaved centrally to two molecules 
of retinal, converted to retinyl esters and then 
transported to the liver as described above. Some 
intact carotenoids can also be transported to the 
peripheral tissues via Chylomicrons. In peripheral 
tissues, they can be further transformed into 
retinoids (Perrotta et al 2003; Debier & Larondelle 
2005; Harrison 2005). The conversion of β-
carotene to retinol is regulated so that excess 
retinol is not absorbed from carotene sources 
(Underwood 1985; Bendich & Langseth 1989)
2.3.2 Storage and blood transport
Chylomicrons containing newly absorbed retinyl 
esters are released into the blood circulation 
via the lymph, and Chylomicron remnants are 
formed in blood capillaries. Most of the retinyl 
esters in the Chylomicrons remnants are taken 
up by the liver. In liver parenchymal cells, retinyl 
esters are rapidly re-hydrolysed to retinol. Free 
retinol binds to a specific transport protein, RBP. 
Retinol bound to RBP (holo-RBP) can be secreted 
directly into the circulation or transferred to the 
stellate (fat storing) cells and stored in the form 
of long-chain fatty esters (Debier & Larondelle 
2005; Harrison 2005).
About 90% of the total body vitamin A reserves 
are stored in the liver, within the adipose tissue, 
extrahepatic stellate cells in lungs, kidneys and 
intestine as minor sites (Tsutsumi et al. 1992; 
Olson 1996; Nagy et al. 1997). Unlike retinoids, 
carotenoids are deposited mainly in adipose 
tissues and relatively small amounts are stored 
in the liver (Goodman 1984; Olson 1984).
When needed, stored retinol is transferred back 
to parenchymal cells and released into the 
circulation as holo-RBP. Homeostatic mechanisms 
regulate mobilization and release of holo-RBP 
ensuring that plasma retinol concentrations 
remain constant, the range under normal 
conditions being 1-3 µmol/L (Underwood 1979; 
Olson 1996 & 2001; Thurnham & Northrop-Clewes 
1999; Penniston & Tanumihardjo 2006). 
2.3.3 Tissue uptake 
Retinol is believed to enter the target cells mainly 
as holo-RBP. Depending on tissue type, retinol is 
either transformed into retinyl ester and stored 
in lipid droplets (adipose tissue) or activated into 
retinoic acid or retinal (eyes, lungs) (Debier & 
Larondelle 2005). 
2.4 Bioavailability 
Under normal physiological conditions about 
70-90% of ingested preformed vitamin A is 
absorbed. The absorption efficiency of provitamin 
A carotenoids is much lower, ranging from 5% 
to 50% (Blomhoff et al. 1991; Garrow et al. 
2000).  The absorption is influenced by a number 
of factors including type and amount of the 
vitamin A source consumed, food matrix, food 
processing, the fat content of the accompanying 
meal (Ribaya-Mercado 2002). Oil solutions of 
carotenoids seem to be more bioavailable than 
those from food matrices, and heating can 
improve the bioavailability of carotenoids from 
some food products (Parker et al. 1999, van 
Lieshout 2001; Ribaya-Mercado et al. 2007). 
2.5 Biological functions
Vitamin A is an essential nutrient for all animal 
species because of its critical role in vision, 
gene expression, reproduction, embryonic 
development, growth, and immune function 
(Perrotta et al. 2003; Villamor & Fawzi 2005). 
These roles are particularly critical during periods 
of proliferative growth and tissue development, 
as in pregnancy, infancy, and early childhood 
(Underwood 1994a, b). 
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The main active form of vitamin A is retinoic 
acid. Cellular retinoic acid can be obtained from 
either the conversion of retinol to retinal and 
then to retinoic acid or direct uptake from blood 
circulation. The two biologically active isomers 
of retinoic acid are all-trans-retinoic acid and its 
9-cis isomer. Retinoic acids act as regulators of 
genomic expression and are considered to be 
responsible for all the functions attributed to 
vitamin A, with the exception of vision. Retinoids 
regulate not only transcription via the activation 
of specific retinoid receptors. They can also form 
a covalent bond with some proteins, which can 
modify the properties of the target protein and 
thus its activity (Gerster 1997; Marill et al. 2003; 
Debier & Larondelle 2005). 
The active form of vitamin A in vision is retinal, 
which is derived from circulating retinol and 
retinyl esters. Retinal is essential for vision in 
darkness as well as for colour perception. It is 
situated in the photoreceptors of the retina. 
Two types of photoreceptors are present in the 
retina: rhodopsins and iodopsins. The former are 
situated in the rods and are involved in vision in 
dim light. The latter are present in cones and are 
involved in colour perception and vision in bright 
light (Olson 1984; Debier & Larondelle 2005).  
2.6 Vitamin A intake
2.6.1 Requirement and recommended intake 
The recommended dietary intake (RDI), a term 
used worldwide, or recommended dietary 
allowances (RDA), a term used in the United 
States (US) and in a few other countries, is 
defined as the daily nutrient intake level that 
would theoretically meet the needs of  nearly all 
healthy individuals in a particular life stage and 
gender group. A RDI or RDA is calculated from 
the nutrient’s estimated average requirement 
(EAR) which is the daily nutrient intake level that 
fulfils the average physiological requirements of 
a specified group. RDI or RDA is set at a level 
generously above the EAR but significantly lower 
than the level where toxicological data indicates 
any adverse effects (FNB 2001; NCM 2004). 
The RDI or RDA for vitamin A is based on 
estimated requirements that ensure body stores 
of retinol where no clinical signs of deficiency 
are observed, adequate plasma retinol levels 
are maintained and there is protection against 
vitamin A deficiency for approximately 4 months 
on a vitamin A-deficient diet (NCM 2004). 
Most countries recommend between 500 and 
900 µg retinol equivalents (RE) for adults per 
day (NCM 2003). Finnish recommendations (VRN 
2005) for vitamin A intake for adults are equal 
to Nordic (NCM 2004) and US recommendations 
(FNB 2001). EAR is 600 and 500 µg/d and 
RDI 900 and 700 µg/d for men and women, 
respectively.  
Extrapolating data from adults to children 
and adolescents
For infants aged 0 to 12 months, adequate vitamin 
A intake can be determined by estimating the 
intake from human milk. Data is not available 
to estimate EAR for children aged 1 year and 
older and adolescents. Therefore, the EAR for 
children and adolescents has been extrapolated 
from those for adults by using metabolic body 
weight (kg0.75) and growth factors (FNB 2001; 
NCM 2004). 
The extrapolation method assumes that 1) 
Maintenance needs for vitamin A, expressed with 
respect to metabolic body weight [(kilogram of 
body weight)0.75], are the same for adults and 
children, 2) The EAR for adults is an estimate 
of maintenance needs, 3) The proportion of 
extra vitamin A needed for growth is similar 
to the proportion of extra protein needed for 
growth and is used as an estimate of the growth 
factor, 4) On average, total needs do not differ 
substantially for males and females until age 14, 
when reference weights differ (FNB 2001). 
The formula used for the extrapolation (FNB 
2001) is 
EARchild = EARadult x [(weightchild/weightadult) 
0.75 x (1 + growth factor)]
where weightchild and weightadult are reference 
weights and 
where the average proportional increase in 
protein requirement for growth is used as an 
estimate of the growth factor. Reference weights 
and growth factors used by the US Institute of 
Medicine (FNB 2001) are shown in table 2. 
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Table 2. Reference weights and growth factors for children and adults in the US (FNB 2001)
Gender Age Reference weight (kg) Growth factor
Male, female 2-6 mo 7
7-11 mo 9 0.3
1-3 y 13 0.3
4-8 y 22 0.15
Male 9-13 y 40 0.15
14-18 y 64 0.15
19-30 y 76
Female 9-13 y 40 0.15
14-18 y 57 0
19-30 y 61
Recommendations for infants, children and 
adolescents
Finnish recommendations for vitamin A intake for 
children and adolescents (Table 3; VRN 2005) are 
equal to Nordic recommendations (NCM 2004), 
i.e. 300-600 µg RE/day, which are primarily 
based on assumptions and calculation methods 
used for United States reference subjects (FBN 
2001). An adequate intake (AI) for infants (0-
6 mo: 400  µg RE/day, 7-12 mo: 500 µg RE/
day) used in the USA reflects a calculated mean 
vitamin A intake of infants principally fed human 
milk (FNB 2001). In Nordic countries, specific 
recommended intake of vitamin A for infants 
aged 0-6 months has not been given, because 
breast milk from well-nourished mothers usually 
contains sufficient amounts of vitamin A and 
vitamin A content of formula is sufficient for non-
breast fed infants (NCM 2004). 
The recommendations of FAO/WHO differ slightly 
from those of Nordic and US recommendations. 
This is due to different definitions of dietary 
reference intakes for vitamin A. The FAO/WHO 
defines the “mean requirement” for vitamin 
A as the minimum daily intake to prevent 
xerophthalmia in the absence of clinical or sub-
clinical infection. The recommended safe intake 
is defined as the average continuing intake of 
vitamin A required to permit adequate growth 
and other vitamin A-dependent functions and to 
maintain an acceptable total body reserve of the 
vitamin (FAO/WHO 2002). 
In order to prevent excessive intake of vitamin 
A, liver-based foods are not recommended for 
children under the age of one year in Finland. For 
toddlers, the consumption of liver-based foods 
(ground liver patties, liver steak, liver stew, liver 
casserole), liver sausage and liver pâté have been 
advised to be restricted to a couple of meals per 
month. The recommendations date back to the 
beginning of the1990s. 
2.6.2 Current intake
Based on the results of a Finnish STRIP-study 
in 1995, on average Finnish children receive 
an adequate amount of vitamin A from food. 
Compared to the dietary recommendations, 
the intake of vitamin A from the diet of Finnish 
children is even more than adequate (Table 4). 
In the USA, the mean vitamin A intakes are also 
well above the recommended levels in all age 
groups (NHANES survey in 1999-2000; Ervin et 
al. 2004).  For children aged 1-3 y, the median 
vitamin intake from food was 484 µg of retinol 
activity equivalent/d (RAE/d), and the 95th 
percentile was 1259 µg of RAE/d. The median 
intake from supplements was 721 µg of RAE/d, 
and the 95th percentile was 1482 µg of RAE/d. 
There is no evidence however, that these levels 
of intake would have caused toxicity in the United 
States (FNB 2001; Allen & Haskell 2002). 
Intake of vitamin A from liver foods among Finnish 1-, 3-and 6-year-old children – a quantitative risk assessment
25
Table 3. Vitamin A intake recommendations for infants, children and adolescents (µg RE/day).
Source/age group Estimated average 
requirement (EAR)
Recommended daily intake (RDI)
Finland (VRN 2005)
6-11 mo 300
12-23 mo 300
2-5 y 350
6-9 y 400
10-13 y 600
14-17 y
male 900
female 700
USA (FNB 2001)
1-3 y 210 300
4-8 y 275 400
9-13 y
male 445 600
female 420 600
14-18
male 630 900
female 485 700
FAO/WHO1 (2000)
0-6 mo 180 375
7-12 mo 190 400
1-3 y 200 400
4-6 y 200 450
7 y 250 500
10-18 y 330-400 600
1Mean requirement and recommended safe intake.
Table 4. Vitamin A intake among children in the Turku area (Finnish STRIP-study,  
1995 in Hasunen et al. 2004).
Age Average intake µg RE/day 
13 mo 717
2 y 665
3 y 776
4 y 880
5 y 875
6 y 836
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3. Hazard characterisation of vitamin A
3.1 Vitamin A deficiency
Vitamin A deficiency (VAD) is rare in the Western 
world, but is a leading cause of growth failure, 
morbidity, mortality, and blindness in developing 
countries. It can occur in individuals of any age. 
However, it is a disabling and potentially fatal 
public health problem in developing countries for 
children under 6 years of age (FAO/WHO 2002; 
Underwood 2004). 
The first specific symptom associated with VAD 
include visual problems such as night blindness 
and xerophthalmia (xero = dry, ophthalm = eye) 
that may end in irreversible blindness. VAD-
dependent blindness is most prevalent in children 
under 3 years of age. It’s also well known that 
VAD causes immunodeficiency, which may occur 
among children as respiratory and digestive tract 
infections (Cser et al. 2004).  It also results in 
anaemia regardless of the iron status of the body 
(West 2003). There is also consistent evidence that 
an increased intake of vitamin A in developing 
countries, achieved by supplementation or food 
fortification, can improve the survival of infants 
and young children (Villamor & Fawzi 2000; 
McLaren & Frigg 2001; D´Souza & D´Souza 2002; 
West 2002; Benn et al. 2003; Benn et al. 2005). 
There are three main causes of vitamin A 
deficiency in young children. Their mothers 
might be deficient and produce breast milk low 
in vitamin A or they are weaned onto diets that 
provide too little vitamin A. A third contributing 
factor is that children in developing countries are 
so often ill, that anorexia, malabsorption and 
increased catabolism further deteriorate their 
vitamin status (Miller et al. 2002). In addition, 
plant foods containing provitamin A carotenoids 
often are the primary sources of vitamin A in 
some populations. Thus, strategies for improving 
the absorption and bioconversion of plant 
carotenoids are essential (Oso et al. 2003; Ribaya-
Mercado et al. 2007). 
3.2 Retinoid toxicity
3.2.1 Hypervitaminosis A
Retinoids are fat soluble and readily accumulate 
in the liver. Their absorption is rapid and clearance 
slow. As a result, excess intake of retinoids can 
result in hypervitaminosis A among children and 
adults or teratogenicity during the foetal stage 
(Hathcock 2004). Consuming natural sources of 
vitamin A rarely result in toxicity. The exception is 
toxicity resulting from excessively high intakes of 
liver or use of food supplements on a continued 
basis.
Toxicity appears to occur only when the amount 
of retinoids present exceeds the capacity of 
retinol binding proteins (RBP) to bind to them. 
Retinoids that are not bound to RBP bind to 
lipoproteins, and in this form they have toxic 
effects. In other words, in vitamin A toxicity, 
plasma RBP levels are normal but concentrations 
of retinoids not bound to the specific RBP are 
increased (Smith and Goodman 1976; Perrotta 
et al. 2003). Overconsumption of carotenoids has 
not been shown to result in hypervitaminosis A, 
presumably because its cleavage to retinoids is 
tightly regulated (Bendich 1988; Dawson 2000).
Vitamin A toxicity in humans may be generally 
categorized as either acute or chronic. Acute 
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toxicity occurs within hours or at most a day or 
two after a very large intake. Chronic toxicity 
occurs when lesser amounts that are not acutely 
toxic are consumed for several weeks, months, 
or years. Biological indicators of toxicity include 
high serum retinol concentrations, production of 
toxic metabolites, high vitamin A concentrations 
in the liver and liver damage (Allen & Haskell 
2002). 
In general, acute toxicity is less of a problem 
than is chronic toxicity from preformed vitamin A 
(Olson 2001; Penniston and Tanumihardjo 2006). 
Acute cases are, however, mostly reported among 
small children 0-2 years old, whereas chronic 
hypervitaminosis is more common in older age 
groups (Myhre et al. 2003). 
3.2.2 Symptoms
The pattern of adverse symptoms varies with 
the dose and the duration of exposure as well 
as with the age of the individual exposed. Myhre 
et al. (2003) performed a meta-analysis of 
case reports on toxicity claimed to be induced 
by intakes of excessive amounts of retinol and 
retinyl esters in foods or supplements. Table 5 
shows symptoms registered in cases with acute 
or chronic hypervitaminosis A. Of the 259 cases 
registered, 55 were acute and 204 chronic. Of 
those reporting the source of retinol, 4, 24, 36, 
and 32 cases came from ingestion of retinol 
in liver, oil, emulsified and water-miscible 
solutions, and solid tablets, respectively. Almost 
all of the subjects with acute hypervitaminosis 
(50 cases) were in the age group 0-2 years. Most 
of these acute cases experienced symptoms of 
the nervous, visual, and gastrointestinal systems. 
Over one third of the group reported general 
symptoms of a deteriorating state of health (e.g. 
fever, loss of appetite, and fatigue). For the age 
groups 0-2 years (n=50)  and 3-16 years (n=39), 
symptoms of the skin, visual, nervous system, 
gastrointestinal system, and musculoskeletal 
system, and general symptoms of a deteriorating 
state of health were reported in over 50% of the 
chronic cases. 
Table 5. Symptoms registered in cases with acute or chronic hypervitaminosis A among children 
aged 0-16 years (Gamble & Ip 1985; Hathcock et al. 1990; Myhre et al. 2003).
Nervous system and vision Bulging of fontanel, Headache, Cerebral irritability, Papillary 
edema, Hydrocephalus, Increased CSF pressure, Diplopia, 
Pseudotumour cerebri, Ataxia, Blurred vision, Disturbance of 
consciousness
Gastrointestinal system Vomiting, Nausea, Abdominal pain, Hepatomegaly, 
Splenomegaly
Vascular system Edema: head, leg or ankle, abdomen
Musculoskeletal system Hyperostosis, Skeletal pain, Muscular stiffness and pain, Joint 
pain
Skin and hair Lip fissure, Alopecia, Pigmentation, Dryness, Desquamation, 
Pruritus, Pale, Haemorrhage, Exanthema
Urogenital system Menstrual change
Symptoms of deteriorating 
state of health
Loss of appetite, Fatigue, Tiredness, Fever, Impaired immunity, 
Weight loss, Sleep disturbance
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3.2.3 Dose response
Intake of retinol in various physical forms ap-
pears to have different thresholds for toxicity. Re-
tinol in water-soluble, emulsified or solid prepa-
rations generally seems to have more acute toxic 
effects than retinol in foods or oils (Myhre et al. 
2003). It is known from a series of studies that 
retinol is absorbed much better from emulsified 
than oily solutions (NCM 2003).
Acute toxicity
According to Olson (2001), acute toxicity in 
children may even begin with doses of > 20 x 
the RDA for vitamin A. For 1-3-year-old children 
this would mean doses of > 460 µg RE/kg. In 
adults, doses > 100 x RDA may cause acute to-
xicity. In the meta-analysis carried out by Myhre 
et al. (2003) using 259 hypervitaminosis A cases, 
acute toxicity was seen with supplemental do-
ses of  3 500- 29 200 and 8 000-16 700 µg RE/
kg body weight in children aged 0-2 (n=50) and 
3-16 (n=3) years, respectively. They concluded 
that the safe upper single dose of retinol in oil 
or liver for infants and small children is ~ 3 000- 
3 500 µg RE/kg body weight, whereas water-
miscible and emulsified forms of retinol have a 
lower threshold. For adults, the safe upper single 
dose of retinol in oil or liver is ~ 4 000-6 000 µg 
RE/kg body weight (Myhre et al. 2003). Table 6 
shows tentative cut-off levels proposed by Allen 
& Haskell (2002). They are levels in the diet or 
in body tissues that indicate there may be some 
risk of toxicity.   
Chronic toxicity 
Onset of chronic toxicity is dependent on the 
dose and the length of exposure. According to 
Olson (1987), toxic doses are at least 10 times 
higher than the RDA (1-3 year olds: > 230 µg RE/
kg body weight) and usually cannot be obtained 
from foods except by the chronic ingestion of sig-
nificant amounts of liver. For children, daily inta-
kes of 450 µg/kg body weight have reportedly 
led to toxicity (Bendich et al. 1989; Hathcock et 
al. 1990; Coghlan & Cranswick 2001; Penniston 
and Tanumihardjo 2006). In the meta-analysis of 
Myhre et al. (2003), chronic toxicity was reported 
with daily doses of 190-18 800 and 70-4600 µg 
RE/kg body weight in children aged 0-2 (n=50) 
and 3-16 (n=39) years, respectively. Chronic hy-
pervitaminosis was concluded to be induced af-
ter daily doses of 2 000 µg RE/kg in oil-based 
preparations for many months or years (Myhre 
2003). In contrast, doses as low as 200 µg RE/kg 
in emulsified/water-miscible and solid preparati-
ons for only a few weeks seemed to cause chro-
nic hypervitaminosis A (Myhre et al. 2003).
Tolerance to excess vitamin A intake has also 
been seen to vary between individuals. In one 
case study, two boys were given chicken li-
ver that supplied about 690 µg/day vitamin A 
and various supplements that supplied another 
135 to 750 µg/day. One boy developed toxicity 
symptoms at the age of 2 years, and the other 
one at the age of 6 years. An older sister who 
had been treated similarly remained completely 
healthy (Carpenter et al. 1978; FNB 2001). 
Table 6. Cut-off levels for vitamin A toxicity in the diet or in body tissues (µg/d) (Modified from 
Allen & Haskell 2002). 
Outcome Group Intake Concentration
Acute toxicity symptoms Infant 0-6 months 15 000 µg dose 
(2 100 µg/kg)1
Infant 7-11 months > 30 000 µg dose  
(3 300 µg/kg)1
Child > 12 months 30 000 – 60 000 µg dose 
(3 300 – 4 600 µg/kg)1
Liver damage/chronic 
toxicity symptoms
Infants/children > 1 000 µg /d, long term 
(140 µg/kg/d)1
Excessive liver 
accumulation
Women and children 300 µg/g
High serum retinol Women and children > 100 μg/dL
1Intake/kg body weight calculated by using following reference weights (FBN 2001):  
2-6 mo 7 kg, 7-11 mo 9 kg, 1-3 y 13 kg
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3.2.4 Tolerable upper levels 
The tolerable upper level (UL) is defined as the 
highest level of daily nutrient intake that is likely 
to pose no risk of adverse health effects for 
almost all individuals in the general population. 
As intake increases above the UL, the risk of 
adverse effects increases. If possible the UL is 
derived from the no observed adverse effect 
level (NOAEL), which is the highest intake at 
which no adverse effects have been reported or 
from the lowest observed adverse effect level 
(LOAEL), which is the lowest intake at which 
an adverse effect has been identified. The UL is 
several-fold lower than the NOAEL or LOAEL, and 
it is derived by dividing the NOAEL (or LOAEL) by 
a single uncertainty factor that incorporates all 
relevant uncertainties. 
The Institute of Medicine in the USA (FNB 
2001; Allen & Haskell 2002) and the Scientific 
Committee on Food (SCF) in the EU (SCF 2002) 
have recommended ULs for vitamin A intake 
(Table 7). Because, there is more data on which 
to base the NOAEL for infants than there are for 
children over 12 months of age, the UL values for 
children and adolescents have been extrapolated 
from the value of 3000 µg RE/d for adults. The 
US Institute of Medicine uses reference body 
weights in the extrapolation, when the formula 
is  
ULchild = ULadult x Weightchild/Weightadult
where 
ULchild is extrapolated UL-value of specific child 
age group 
ULadult is the value for adults; 3000 µg RE/d
Weightchild and Weightadult are reference body 
weights for children and adults (Table 3). 
The extrapolation used by SCF is also based on 
the value of 3000 µg RE/d for adults but the 
correction for differences in basal metabolic rate 
compared to adults uses scaling according to 
body surface area (body weight0.75), which gives 
slightly higher UL-values than the use of  the 
simple ratio of body weights. Thus, the formula 
is 
ULchild = ULadult x (Weightchild/Weightadult)
0.75
Table 7 shows the UL values for preformed 
vitamin A intake of children and adolescents. 
When compared to recommended intakes above 
in Table 3, it can be seen that the ULs are 2-3 
times higher than recommended daily intakes.
Table 7. Tolerable upper level (UL) for preformed vitamin A (retinol and retinyl esters; µg RE/d) 
(FBN 2001; Allen & Haskell 2002; SCF 2002).
Age years
UL
Institute of Medicine, USA SCF
< 1 6001
1-3 6002 8002
4-8 9002
4-6 11002
7-10 15002
9-13 17002
11-14 20002
14-18 28001
15-17 26002
1 Derived from the NOAEL or LOAEL
2 Extrapolated from the value of 3000 µg RE/d for adults
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4. Exposure assessment
4.1 Data sources
For exposure assessment, the following data 
sources were used:
1. The consumption of liver products among 1-, 
3- and 6-year old Finnish children was obtained 
from the Finnish Type I Diabetes Prediction and 
Prevention (DIPP) Nutrition Study (Kupila et al., 
2001, Virtanen et al. 2006). 
2. Laboratory analyses of swine, bovine and 
chicken liver samples, carried out to obtain 
information on retinoid content in the raw 
material of liver foods, were obtained from 
the previous MAVIRA-project (Lavikainen et al. 
2007). 
3. The amount and type of liver in the consumed 
liver foods were estimated relative to the market 
shares of all Finnish liver products. The market 
shares and recipe information were obtained 
from the industry and the National Public Health 
Institute of Finland.
4. Data of retinoid and vitamin A intake from 
non-liver sources was also obtained from the 
DIPP Nutrition Study.
Based on the collected data, Monte Carlo 
simulation models were built to estimate 
children’s vitamin A and retinoid intake whether 
liver foods are eaten or not. Results were 
compared with the intake recommendations for 
vitamin A and with the intake limits for retinoids. 
The models were also applied to estimate safe 
portion sizes and eating frequencies of liver 
foods. 
4.1.1 DIPP Nutrition Study design 
Data on consumption of liver products and intake 
of retinoids and vitamin A from non-liver foods 
and food supplements was obtained from the 
DIPP Nutrition Study. The data is from the years 
2003-2006.
The DIPP study was established to predict type 
1 diabetes and to develop effective strategies to 
prevent or delay progression of β-cell destruction 
to clinical disease in Finland (Kupila et al., 2001). 
The DIPP study was carried out in the University 
Hospital areas of Turku, Tampere and Oulu. 
Families with a newborn baby with genetic 
susceptibility for type 1 diabetes were invited to 
take part in the study. 
Food consumption data were obtained from the 
DIPP Nutrition Study in the cities of Tampere 
and Oulu. The DIPP Nutrition Study aimed at 
characterizing prenatal and postnatal nutritional 
factors that relate to natural progression from 
genetic disease susceptibility to development of 
β-cell autoimmunity and further clinical type 1 
diabetes. The parents and other caregivers (e.g. 
staff at day-care centres) recorded the child’s 
food consumption using 3-day food records that 
included one weekend day. The families and 
day-care personnel received oral and written 
instructions to record with household measures 
(e.g. spoons, cups, glasses, pieces and decilitres) 
all the foods the child had eaten. Parents and 
day-care personnel also recorded the type, brand 
and preparation method of the foods used. The 
vitamin and mineral supplements used were 
recorded with their brand names and amounts 
as tablets, drops, spoonfuls or millilitres. A 
research nurse reviewed the records item by 
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item for completeness and accuracy, during the 
respective study visit after each recording period. 
When needed, missing data (e.g. portion sizes, 
food descriptions and food preparation methods) 
were added after a discussion with the mother 
or father. The research nurses and physicians 
received continuous education (from the research 
nutritionist) in order to be able to advise the 
parents to fill in the child’s food records and to 
check the forms for possible contradictions and 
omissions.   
The food consumption data was analyzed using 
an in-house software program developed by the 
National Public Health Institute (Ovaskainen et al., 
1996). Nutrient values of the food composition 
database are mainly derived from chemical 
analyses of Finnish foods and are continuously 
updated by complementary data obtained from 
the Finnish food industry and international food 
composition tables. The database currently 
includes about 3000 individual food items and 
mixed dishes and more than 200 nutrients and 
other dietary factors. The system also allows 
creation or modification of specific recipes, which 
were used when appropriate. Standard recipes 
in the database are based on current Finnish 
cook books. Nutritional information of those 
food supplements registered as drugs in Finland 
were obtained from the Finnish pharmacopoeia. 
Information on food supplements other than 
drugs was obtained from the National Food 
Administration and the manufacturers.
4.2 Reported consumption of liver 
In total, 12 (1.2%) of 963 one-year-old children, 
150 (18.0%) of 835 three-year-old children and 
155 (18.2%) of 850 six-year-old children reported 
liver consumption. All 1-year-old liver consumers 
ate only one liver food during the 3-day study 
period whereas 7 to 8% of 3- and 6-year-old liver 
consumers ate two liver foods during the study 
period. The most commonly eaten liver food was 
liver sausage or pâté followed by liver casserole. 
No 1-year-old and only few 3- and 6-year-olds 
ate liver sauce or liver patties (Table 8).
4.2.1 Reported eating frequencies 
Eating frequency was defined as the number of 
study days when certain liver foods were eaten. 
All 1-year-old liver consumers ate liver foods 
only on one day during the 3-day study period 
whereas some 3- and 6-year old liver consumers 
ate liver sausage or pâté on all three days and 
liver casserole on two days. Eating frequencies 
are expressed in Table 9.
4.2.2 Reported portion sizes
Portion size was defined as the amount of liver 
food consumed during a day (g/day). Portion 
sizes are expressed in Table 10. The range 
of portions sizes for liver sausage or pâté and 
liver casserole varied between age groups and 
variation occurred also within each age group. 
However, the mean and median portion sizes of 
liver sausage or pâté were very similar between 
all age groups, whereas those of liver casserole 
increased with increasing age. The number of 
both liver sauce and liver patty portions was 
low and gave only some references of relevant 
portion sizes.
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Table 8. Reported use of different liver foods among 1-, 3- and 6-year-old children during the 3-
day period in the DIPP Nutrition Study (1-year-olds: n = 963, 3-year-olds: n = 835, 6-year-olds: 
n = 850).
Table 9. Reported number of days when liver foods were eaten among 1-, 3- and 6-year-old 
children in the DIPP Nutrition Study. 
Age/Liver food
Number of 
consumers
Proportion of consumers (%)
Among liver 
consumers Among all children
1 year
Liver sausage or pâté 6 50 0.6
Liver casserole 6 50 0.6
Liver sauce 0 - -
Liver patties 0 - -
3 years
Liver sausage or pâté 92 61.3 11.0
Liver casserole 66 44.0 7.9
Liver sauce 1 0.7 0.1
Liver patties 3 2.0 0.4
6 years 
Liver sausage or pâté 92 59.4 10.8
Liver casserole 68 43.9 8.0
Liver sauce 6 3.9 0.7
Liver patties 1 0.6 0.1
Age/Liver food 
Number of eating days during 3-day study
0 1 2 3
1 year     
Liver sausage or pâté 957 6 0 0
Liver casserole 957 6 0 0
3 years     
Liver sausage or pâté 743 65 23 4
Liver casserole 769 58 8 0
Liver sauce 834 1 0 0
Liver patties 832 2 1 0
6 years     
Liver sausage or pâté 758 64 19 9
Liver casserole 782 61 7 0
Liver sauce 844 6 0 0
Liver patties 849 1 0 0
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Table 10. Reported portion sizes of liver foods among 1-, 3- and 6-year-old children in the DIPP 
Nutrition Study. 
Age/Liver food Number of portions
Portion size (g)
Mean Median Range
1 year
Liver sausage or pâté 6 17 15 5-30
Liver casserole 6 77 48 5-180
Liver sauce 0 - - -
Liver patties 0 - - -
3 years
Liver sausage or pâté 123 20 15 2-70
Liver casserole 74 117 100 5-300
Liver sauce 1 100 - -
Liver patties 4 40 40 30-50
6 years 
Liver sausage or pâté 129 20 15 2-80
Liver casserole 75 151 150 10-450
Liver sauce 6 96 100 50-150
Liver patties 1 30 - -
4.3 Production of liver foods
4.3.1 Liver in liver foods
To quantify the liver content of consumed liver 
foods, recipe information was used. For commer-
cially available prepared liver foods (liver casse-
role and liver sausage and pâté), recipes were 
obtained from the Finnish food industry. For liver 
patties and liver sauce, which were not availab-
le as prepared food, the customary recipes of the 
National Public Health Institute of Finland were 
used. Information was gathered on both the 
amount and the type of liver (animal species). 
The amount of liver was reported as a percen-
tage of the weight of the end product, i.e., the 
amount of raw liver (g) needed to produce 100 g 
of end product. Thus, the water loss during food 
manufacture was included in the numbers. 
Finnish liver food manufacturers supplied the re-
cipes of prepared liver foods. Reported liver con-
tents were then weighted relative to the market 
shares in year 2004. The results are summarised 
in Table 11. Information was received on all but 
three products with a small market share (0.3-
0.9%). In liver sausage and pâté, pork liver was 
the main  ingredient, whereas in liver casserole 
several liver types are mixed and used in very 
variable proportions. Although the type of liver 
used may vary, the total liver content of the pro-
ducts is kept very constant by each manufacturer. 
The mean liver content in liver sausage or pâté 
was 20.5% (range 8-42%) and in liver casserole 
13.6% (range 10-21%) (Table 11). 
For liver patties and liver sauce, the following 
common recipes were obtained from the Natio-
nal Public Health Institute of Finland:
liver patties: liver content 50%; one-third 
swine liver and two-thirds bovine liver.
liver sauce: liver content 33%; one-third 
swine liver and two-thirds bovine liver.
In the recipes, swine liver includes both finis-
hing pig liver and sow liver. According to Finnish 
food manufacturers, sow livers, however, make 
up no more than 10% of the swine livers used. 
Because the risk assessment of Lavikainen et al. 
(2007) showed that exclusion of sow livers from 
food production would have only a minor effect 
on retinoid intakes from liver foods, higher reti-
noid contents of sow livers were not taken into 
account but in the calculations all swine liver was 
supposed to be the finishing pig liver. 
−
−
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Table 11. Liver content of Finnish industrial liver foods obtained from food manufacturers. 
Contents are calculated as an arithmetic mean and as a weighted mean relative to market share. 
N = number of trade names with content information available/number of trade names on sale in 
2004 (Lavikainen et al. 2007).
Product and statistics
Total liver 
content (%)1
Type of liver (% of total liver content)
Pig Bovine Chicken
Liver sausage and pâté 
(n=24/27)
• Mean (min-max) 18.4 (8-42) 95.8 (0-100) 4.2 (0-100) 0
• Weighted mean 2 20.5 98.9 1.1 0
Liver casserole (n=7/7) 
• Mean (min-max) 14.1 (10-21) 64.5 (0-100) 18.3 (0-100) 17.2 (0-45)
• Weighted mean 2 13.6 67.5 3.4 29.1
1Amount of raw liver component as a percentage of weight of the end product.
2Relative to market share.
4.3.2 Size of production run
The size of the production run can affect the run-
to-run stability of the final retinoid content of the 
product. If a large amount of food is produced 
at a time, the amount of liver used is also large, 
and livers with high and low retinoid content 
compensate for each other. On the contrary, if the 
production run is small with only one or a few 
livers in a run, the final retinoid content varies 
more due to chance.
Among Finnish food manufacturers, the sizes of 
single production runs vary depending on the 
production volume and the amount of purchase 
orders. One batch of liver sausage or pâté can 
use 20-120 kg of liver. For liver casserole, one 
batch uses around 170 kg of liver among the 
large manufacturers. Liver patties and liver 
stew are served in canteens and restaurants in 
different volumes. Liver foods are also made in 
small quantities at home. The volumes of liver 
used in both of these instances can be expected 
to be lower than in industrial production but are 
unknown.
4.4 Vitamin A (retinoids) in liver  
4.4.1 Sampling and analytical methods
Sampling of liver samples from bovine, swine 
and chicken and analytical methodology used 
to determine liver vitamin A content have 
been explained in detail by Lavikainen et al. 
(2007). Briefly liver samples were collected 
from Finnish slaughterhouses during the spring 
of 2005. Bovine and swine livers were treated 
as individual samples, but, among chickens, 
each sample comprised  the livers of ten birds 
from the same producer. All the chickens were 
slaughtered at the age of 35 days and pigs at 
the age of six months. The age of bovines varied 
from 13 months to 12 years. 
Pre-treatment of the samples involved sample 
homogenisation, protein precipitation and liquid-
liquid extraction. Retinol, retinyl esters and ß-
carotene (only from bovines) were analysed 
from liver samples with high-performance 
liquid chromatography (HPLC) using diode array 
detection at 325 nm. The analysing procedure 
was based on the methods of Barua et al. (1998) 
and van Merris et al. (2002).
4.4.2 Retinoid content of livers
Liver vitamin A content (µg RE/g) in each sample 
was calculated as a sum of the analysed vitamin 
A activity of retinol and retinyl esters. The 
vitamin A activity of ß-carotene was not taken 
into account, because its impact on total vitamin 
A activity would have been negligible. Liver 
vitamin A (retinoids) content, used in simulation 
of retinoid intakes, are shown in Figure 3.
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Figure 3. Measured liver retinoid content in pigs, bovines and chickens.
Pig liver
n = 91
Mean : 170 μg RE /g
Med ian : 164 μg RE /g
Range : 28 -549 μg RE /g
Bovine liver
n = 76
Mean : 213 μg RE /g
Med ian : 175 μg RE /g
Range : 44 -744 μg RE /g
Chicken liver
n = 27 (poo led samples of 10 live rs)
M ean : 106 μg RE /g
Med ian : 97 μg RE /g
Range : 34 -277 μg RE /g
Intake of vitamin A from liver foods among Finnish 1-, 3-and 6-year-old children – a quantitative risk assessment
36
4.5 Daily intake of vitamin A from 
non-liver sources
Intake estimates of vitamin A from non-liver 
sources were based on the 3-day DIPP Nutrition 
Study data. Both natural and supplemental intake 
was estimated using the method of Nusser and 
co-workers (1996). The method gives the long-
run average of daily intakes (usual daily intake) 
by taking into account day-to-day correlation 
and nuisance effects (such as day-of-week and 
interview sequence). It also allows exceptions 
from normality through grafted polynomial 
transformations and recognises the measurement 
error associated with one-day dietary intakes. 
Estimates were done using the SAS based SIDE® 
program.  In carotenoid intake calculations, the 
following ratios were used: 1 µg RE = 12 µg 
of dietary ß-carotene = 24 µg of other dietary 
provitamin A carotenoids.
Among 1-, 3- and 6-year-old children, the median 
intake of total vitamin A from non-liver sources 
was 235, 329 and 428 µg RE/day respectively 
and that of retinoids 79, 219 and 290  µg RE/
day respectively. Non-liver derived intake was 
similar among liver eaters and non-liver eaters 
for both total vitamin A and retinoids. The intake 
distributions are shown in Figure 4.
1-year-old children
3-year-old children
6-year old children
Figure 4. Reported average daily intakes of non-liver retinoids and vitamin A among 1-, 3- and 
6-year-old children in the DIPP Nutrition Study. 
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4.6 Simulation models
Simulation models were applied to estimate the 
combined contribution of non-liver and liver foods 
on vitamin A and retinoid intake on two different 
scenarios: long term daily average intake by long 
term liver consumption and intake from single 
portions of liver products. 
Vitamin A and retinoid intakes were estimated 
separately for different liver food consumption 
scenarios (liver sausage or pâté, liver casserole, 
liver sauce and liver patties) and for different age 
classes (1-, 3- and 6- year old children).
The simulation models were designed using 
commercial spreadsheet software (Microsoft 
Office Excel 2003, Microsoft Corporation, USA), 
with a commercial add-in module for risk analysis 
(@Risk, version 4.5.2, Palisade Corporation, USA, 
2002). @Risk uses the Monte Carlo method to 
produce possible outcomes. The results of the 
simulation model depend on used input values. 
In the Monte Carlo model, possible input values 
can be described as probability distributions 
instead of point estimates. During the simulation 
process, the chain of events is repeated many 
times (iterations). New input values are 
randomly sampled from probability distributions 
for each iteration. Individual results are then 
combined to produce a probability distribution 
for outcome values. Inputs used in the models 
and empirical parameters on the background of 
fitted distributions are presented in Appendix 1. 
Overall vitamin A and retinoid intake was 
estimated by summing simulated non-liver 
and relevant liver contributed vitamin A/
retinoid intakes for each scenario and age-class 
separately. Distributions of non-liver contributed 
vitamin A and retinoid intakes were estimated 
directly from the distributions of DIPP Nutrition 
Study.
4.6.1 Retinoid content of liver products
Liver content (cLiver
j) of each animal species j 
used in liver products (% in product) and market 
shares of different products within each product 
group (M%) were as in the previous Mavira-
study (Lavikainen et al. 2007).
The size of livers in swine (1.3-1.8 kg) and 
bovines (4.8-7.4 kg) were described as uniform 
distributions while the size of a chicken liver was 
assumed to be 0.05 kg. Weight of liver mass 
used in one production batch was assumed to 
be 100 kg. By simulating average size of livers, 
it was possible to calculate the approximate 
number of livers within a certain batch i (nij) of 
a certain species j. If the product contained livers 
of several species this was taken into account 
by dividing the 100 kg for appropriate sub-
proportions before the estimation of nij.
Measured single liver retinoid content (Mavira-
project, Lavikainen et al. 2007) was fitted by 
@risk to estimate proper distribution assumptions. 
Most concentrations were approximately log-
normally distributed. The parameters were 
then estimated by bootstrapping to gain three 
parameters: mean retinoid content of a single 
liver (mean_cR), standard deviation of single liver 
retinoid content (std_ cR) and the uncertainty of 
standard deviation (un_cR) for each species j 
used for liver products. Uncertainty was assumed 
to be normally distributed. Retinoid content of 
a single batch i of a certain liver product (CRij) 
contributed by a liver of species j could then be 
simulated as 
cRij = e
N[mean = mean_cR ; standard deviation = (N(std_ cR); (un_cR))/ 
 SQRT(nij))]
Where N denotes normal distribution and 
e ~ 2.7182. The function actually uses the 
property of normal distribution where the 
uncertainty of mean could be defined by scaling 
standard deviation by the square root of the 
sample size which equals in this context the 
number of livers of certain species which has 
been used for a certain product batch i. Because 
bootstrapping by Auvtools takes into account log-
normal assumptions by correcting the parameter 
estimates appropriately, there was no need for 
adjusting mean and therefore concentrations 
could be simulated directly as given in the 
equation. 
Retinoid content of a product batch i (cRi) was 
then estimated by summing simulated retinoid 
contents CRij in proportions as appropriate for 
the recipe (cLiverj). Products were sampled in 
proportions of market share (M%) to define the 
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retinoid content of the actual product consumed 
(ConsRi) in an iteration and eating scenario. The 
effect of heating was taken into account by 
multiplying the ConsRii by 0.85 which assumes 
15% reduction in retinoid content. 
4.6.2 Intake of vitamin A and retinoids 
among DIPP-Nutrition study children
The retinoid intakes were estimated by 
multiplying retinoid concentration of the liver 
products by the portion sizes consumed (W) for 
each subject. Three day averages of DIPP study 
portion sizes were used, when the average daily 
intake of vitamin A and retinoids were estimated. 
In the case of single meal intake of retinoids, the 
portion sizes that appeared in the DIPP Nutrition 
Study were used as such. For each simulation, 
the number of iterations was 30 000. 
4.6.3 Proportion and eating frequency of 
apparent eaters
Only one 3-day food record for each respondent 
in the DIPP Nutrition Study caused bias for 
estimation of food consumption frequency of 
those products which may be used more seldom 
than once per 3 days. Thus, the lowest observed 
frequency of any consumption according to the 
data was once per 3 days. If the population on 
average is consuming some items more seldom, 
part of the consumers become apparent non-
eaters and show zero consumption during the 
days of the diary. Eating frequency of apparent 
eaters becomes overestimated similarly since 
the lowest frequency is that once per three 
days. Simultaneously, also the estimation of 
the proportion of true eaters using those rarely 
consumed items become biased (Figure 5). These 
biases are relevant if the safe portion estimate of 
certain liver products for long term consumption 
is aimed to be scaled for the relevant frequency 
of consumption – in other words for the level 
which is nowadays appearing among the Finnish 
population of children. 
Relevant eating frequency for a population was 
estimated by zero-inflated poisson regression 
(Zicounts package, R 2.6.2. software). Both 
eating frequency among true eaters and the 
proportion of true non-eaters were estimated 
simultaneously by zero-inflated poisson 
regression. Estimates were conditional, which 
means that if the proportion of non-eaters is 
over-estimated the frequency of eating among 
true eaters becomes underestimated. The fitted 
model had only two intercepts, one for the 
proportion of true non-eaters and one for the 
lambda of Poisson distribution, which refers to 
the eating frequency.
Figure 5. Schematic illustration of the relationship between true and apparent eaters in short 
term studies.
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4.6.4 Effect of eating frequency on vitamin 
A and retinoid intake by long term liver 
consumption 
For studying safe eating frequencies of liver 
foods, the combined effects of eating frequency 
and portion size were taken into account. In this 
simulation, portion W should be thought of in 
the context of long term average portion size 
when a certain product is consumed. The applied 
range of portions was similar as in single portion 
simulations. They were selected according to 
the ranges that appeared in the DIPP Nutrition 
Study for a certain product group and age class: 
applied distributions were uniform distributions 
(max=maximum in DIPP Nutrition Study, 
min=minimum in DIPP Nutrition Study; Table 
12). Simulations consisted of 35 000 iterations 
per eating frequency.
Eating frequency describes here frequency of 
consumption of a certain liver product. Studied 
eating frequencies were daily, every second 
day, every third day, once a week, once every 
two weeks, once a month and once every two 
months. 
Long term average intake could be estimated by 
multiplying W by r
liver and then multiplying by 
the sampled value of the appropriate retinoid 
concentration distribution of the consumed liver 
product (heat corrected ConsRi). This concentration 
distribution is the same as used for single portion 
simulations and may present more variance than 
production batches of  certain products would 
present in long term follow up studies. By using 
these values we also simulated a situation when 
a person is using only one product of a product 
group. Moreover non-liver contributions were 
described as three day average non-liver retinoid 
contributions – so non-liver contribution presents 
slightly less variation than in single doses. Total 
long term average retinoid intake was then 
estimated by summing non-retinoid and retinoid 
doses of relevant scenarios and age classes.
Table 12. The ranges of liver food portion sizes used in the risk assessment. Ranges were taken 
from the DIPP Nutrition Study
Age/Liver food Portion size range (g) 
1 year
Liver sausage and pâté 5-30
Liver casserole 5-180
3 years
Liver sausage and pâté 2-70
Liver casserole 5-300
Liver sauce 50-150
Liver patties 30-50
6 years 
Liver sausage and pâté 5-80
Liver casserole 5-450
Liver sauce 50-150
Liver patties 30-50
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5. Risk characterization
5.1 Retinoids in liver foods 
Estimated retinoid content of Finnish liver foods 
is presented in Figure 6. The mean retinoid 
content was the highest in liver patties followed 
in descending order by liver sauce, liver sausage 
or pâté and liver casserole. The retinoid content 
varied within the liver food groups reflecting 
variation both in retinoid content of livers used 
as an ingredient and in recipes (liver content) of 
liver foods. 
Figure 6. Retinoid content in Finnish liver foods weighted by market share.  
L ive r sausage and pâ té
Mean: 26 μg RE /g
Maxim um : 59 μg RE /g
L ive r cassero le
Mean: 15 μg RE /g
Maxim um : 41 μg RE /g
L ive r sauce
Mean: 54 μg RE /g
Maxim um : 474 μg RE /g
Mean: 82 μg RE /g
Maxim um : 806 μg RE /g
L ive r pa tties
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5.2 Daily intake of vitamin A and 
retinoids from different sources
Estimated total vitamin A and retinoid intake 
distributions are shown in Figure 7 and Table 
13. The median intake of retinoids was 3.7, 2.7 
and 2.5 times higher among 1-, 3- and 6-year-
old liver eaters respectively than among non-
liver eaters. Independent of the age-group, the 
median intake of total vitamin A was about 2 
times higher among livers eaters than among 
non-liver eaters (Table 13). 
Figure 7. Daily intakes of vitamin A and retinoids among 1-, 3- and 6-year-old children according 
to reported food consumption in the DIPP Nutrition Study. 
Based on simulation results, retinoids constituted 
68%, 82%, and 84% of total vitamin A intake 
among 1-, 3- and 6-year-old liver eaters 
respectively, and 40, 67 and 69% of total vitamin 
A intake among 1-, 3- and 6-year-old non-liver 
eaters respectively. The importance of liver as a 
vitamin A source was clear because among 1-, 3- 
and 6-year-old liver eaters, an average of 56, 57 
and 54% of retinoid intake and 39%, 48% and 
47% of total vitamin A intake came from liver 
foods, respectively. 
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In table 14, the intake estimates are compared 
with reference intakes of vitamin A. Sixteen 
percent (16%) of 1-year-old liver eaters and 
below 10% of 3- and 6-year-old liver eaters 
fell below the recommended vitamin A intake, 
but the average requirement was achieved by 
everyone. Over half of 1- and 3-year-old and 
slightly below half of 6-year-old non-liver eaters 
remained below the recommended intake. Even 
41% of 1-year-old and about 10% of 3- and 6-
Table 13. Daily intakes of retinoids and vitamin A among 1-, 3- and 6-year-old children according 
to reported food consumption in the DIPP Nutrition Study.
Age/Vitamin A 
and retinoid 
source
Retinoids (µg RE/day) Vitamin A (µg RE/day)
Median
5th-5th 
range Maximum Median
5th-5th 
range Maximum
1 year
Food with liver1 290 197-1087 1416 483 237-1273 1621
Food without liver2 79 13-195 559 235 68-527 1028
3 years
Food with liver1 600 238-1656 9900 731 315-1873 10265
Food without liver2 219 112-403 1683 329 179-653 1879
6 years
Food with liver1 743 298-2027 9631 895 376-2167 10242
Food without liver2 290 154-500 1514 428 232-791 1922
1Among liver eaters
2Among all children
year-old non-liver eaters had an intake below 
the estimated average requirement.
In table 15, the retinoid intake estimates are 
compared with upper tolerable intake levels for 
children. Fifteen percent (15%), 34% and 28% 
of 1-, 3- and 6-year-old liver eaters respectively, 
exceeded the recommended upper intake limit. 
Among non-liver eaters, there was no risk of 
exceeding the maximum intake limit
Table 14. Daily intakes of total vitamin A in proportion to reference levels among 1-, 3- and 
6-year-old children according to reported food consumption in the DIPP Nutrition Study.
Age/Vitamin A source
% of children below reference level
< EAR1 < RDI2
1 year
Food with liver3 0 16
Food without liver4 41 68
3 years
Food with liver3 0 8
Food without liver4 9 56
6 years
Food with liver3 0 6
Food without liver4 11 41
1EAR = Estimated average requirement, 
 1- and 3-year-olds 210 µg RE/day, 6-year-olds 275 μg RE/day
2RDI = Recommended daily intake, 
 1-year-olds 300 µg RE/day, 3-year-olds 350 µg RE/day, 6-year-old 400 μg RE/day
3Among liver eaters
4Among all children
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Table 15. Daily intakes of retinoids in proportion to upper tolerable intake levels among 1-, 3- and 
6-year-old children according to reported food consumption in the DIPP Nutrition Study.
Age/Retinoid source
UL1
% of children above UL1 95th percentile / UL1
1 year
Food with liver2 15 1.4
Food without liver2 0 0.24
3 years
Food with liver2 34 2.1
Food without liver2 0.2 0.50
6 years
Food with liver2 28 1.8
Food without liver3 0.1 0.45
1UL = Upper tolerable intake level according to SCF 2002: 
1- and 3-year-olds 800 μg RE/day, 6-year olds 1100 μg RE/day
2Among liver eaters
3Among all children
5.3 Eating frequency among true 
eaters
About 18% of 3- and 6-year-old children 
reported liver consumption during the DIPP-
nutrition study. It is, however, very likely that the 
real proportion of liver eaters among the study 
population was higher and part of the responders 
just didn’t happen to eat liver foods during those 
3 days when they filled in the food record. The 
weakness of the consumption data was that it 
didn’t include information about the proportion 
of liver eaters and non-liver eaters in the real 
population, i.e., the size of the sub-populations 
with possible liver consumption over a long period 
or no liver consumption at all. For these reasons, 
both eating frequency among true eaters and the 
proportion of true non-eaters were estimated by 
zero-inflated poisson regression.  
As a result 24% and 21% of 3- and 6-year-old 
DIPP Nutrition Study children were estimated to 
be true liver sausage or pâté eaters respectively, 
and 38% and 44% true liver casserole eaters 
respectively. True eating frequencies were 
estimated to be every fourth or fifth day and 
every second week for liver sausage or pâté and 
liver casserole respectively (Table 16). For other 
liver foods (liver sauce and liver patties) and for 
1-year-old liver eaters frequencies and proportion 
estimates were not estimable due to the small 
amount of information.
Table 16. Approximated point estimates for eating frequencies among 3- and 6-year-old liver 
eaters by zero-inflated Poisson regression.
Age/Liver food Eating frequency (1/d) Proportion of population (%)
3 years
Liver sausage and pâté 0.20 24
Liver casserole 0.08 38
6 years 
Liver sausage and pâté 0.24 21
Liver casserole 0.07 44
Intake of vitamin A from liver foods among Finnish 1-, 3-and 6-year-old children – a quantitative risk assessment
44
5.4 Single meal retinoid intake
A single meal was defined as an amount of 
certain liver food eaten in one day. Intake 
estimates were calculated separately for every 
liver food studied. The simulated medians, 5th – 
95th percentile ranges and maximum intakes are 
shown in Table 17.
According to Olson (2001), acute toxicity in 
children may even begin with doses of > 20 x 
the RDA for vitamin A. This would mean doses 
over 6 000-8 000 µg RE which are higher than 
the 95th percentile with any liver food or age 
group studied except that with 3- and 6-year 
old liver sauce eaters. Based on meta-analysis, 
Myhre et al. (2003) however, concluded that the 
safe upper single dose of retinol in oil or liver 
for infants and small children is much higher, 
~ 3 000 – 3 500 µg RE/kg body weight, whereas 
water-miscible and emulsified forms of retinol 
have a lower threshold. This means that harmful 
single doses of liver for 1-6–year-old children 
would be over 30 000 – 35 000 µg RE. According 
to Allen & Haskell (2002), a 30 000 - 60 000 µg 
dose of retinoids is the level, that may cause 
acute toxicity for a child over 12 months. 
Results in Table 17 show that only less than 1% 
of liver eaters exceeded the dose 30 000 µg RE. 
This indicates that there is very low risk to be 
exposed to harmful doses of retinoids by eating 
single portions of liver foods.
Table 17. Retinoid intakes (μg RE) from single portions of different liver foods among 1-, 3- and 
6-year-old children in the DIPP Nutrition Study. Intakes are calculated from liver only
Age/Liver food
Intake from single portion (µg RE)
Median 5th-95th range Maximum % > 30000 µg RE
1 year
Liver sausage and pâté 415 119-860 1450 0
Liver casserole 729 64-3062 7135 0
3 years
Liver sausage and pâté 391 103-1520 3129 0
Liver casserole 1723 253-3532 7927 0
Liver sauce 4822 2520-10203 53329 < 1
Liver patties 2849 1302-6736 35528 < 1
6 years
Liver sausage and pâté 411 117-1485 4197 0
Liver casserole 2288 450-4658 11891 0
Liver sauce 4471 1822-10904 46529 < 1 
Liver patties 2192 1146-4688 21317 0
5.5 Safe long term consumption of 
liver foods  
As seen below, single portions of liver foods 
used as portion sizes that appeared in the DIPP 
Nutrition Study, do not very probably expose 
children to harmful doses of retinoids. Instead 
there is a risk to exceed upper tolerable intake 
levels through the long term consumption of 
liver foods. When considering safe long term 
consumption of liver foods, in addition to portion 
size, eating frequency is an important factor.  
5.5.1 Safe eating frequency if one liver food 
is used 
The effect of eating frequency on long term 
retinoid intake was first studied in a situation 
where only one liver food is used. The studied 
eating frequencies were daily, every second 
day, every third day, once a week, once every 
two weeks, once a month, and once every two 
months. In the simulation, portion sizes varied 
in the range that appeared in the DIPP Nutrition 
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Study and retinoid exposure from liver was added 
to retinoid exposure from non-liver sources. 
The effect of eating frequency on the probability 
that the tolerable level of retinoid intake is 
exceeded by eating certain liver food is shown in 
Appendix 2. Probability here means the probable 
percentage where the upper limit of retinoid 
intake in the simulation was exceeded. For long 
term daily retinoid intake, the upper limits set 
by SCF (2002) were used. They were 800 µg RE/
day for 1- and 3-year-olds and 1 100 µg RE/day 
for 6-year-olds. The highest risk to exceed the 
upper limit of retinoid intake is related to the use 
of liver sauce or patties followed in descending 
order by liver casserole and liver sausage or 
pâté. However, all liver foods can be eaten in the 
portion sizes used in the DIPP Nutrition Study by 
choosing the proper eating frequency. 
Table 18 shows safe eating frequencies for each 
age group and liver food when the probability 
that the upper limit of retinoid intake would be 
exceeded is below 1%. The safe eating frequency 
means the time period where the shown portion 
size of liver food can be eaten as one or several 
portions as the total amount of liver food is at 
the maximum the shown portion size. As an 
example, 3-year-olds can eat liver sausage or 
pâté at a maximum of one 70 g, two 35 g or 
seven 10 g portions during one week. 
When only one liver food is used, safe eating 
frequency varies from every second day to once 
every two months depending on the age group, 
liver food and portion size range. The results 
show that 1-year-olds could eat the shown 
portion sizes of either liver sausage or pâté 
(every second day) and liver casserole (once a 
week) more often than 3-and 6-year-olds (once 
a week and once every two weeks respectively). 
This is due to the smaller portion sizes of liver 
foods and also lower retinoid intakes from non-
liver sources among 1-year-olds. 
Consumption of liver sauce and patties was low 
in the  DIPP Nutrition Study. No 1-year-olds had 
eaten liver sauce or liver patties during a 3-day 
period. Therefore the consideration of eating 
frequencies among 1-year-olds was restricted 
to the consumption of liver sausage or pâté 
and liver casserole only. Few 3- and 6-year-olds 
reported the consumption of liver sauce or liver 
patties. The results of simulations shows that liver 
sauce (once every two months and once a month 
among 3- and 6-year-olds, respectively) and liver 
patties (once a month and once every two weeks 
among 3- and 6-year-olds respectively) can be 
eaten more seldom than liver sausage or pâté 
and liver casserole. 
5.5.2 Safe eating frequencies if two liver 
foods are used
It is usual that liver casserole, sauce and patties 
are eaten as a main course and liver sausage or 
pâté as accompaniment. Therefore, the effect of 
eating frequency on long term retinoid intake was 
also studied in a situation where two liver foods 
are used. The studied pairs were 1) liver sausage 
or pâté and liver casserole, 2) liver sausage or 
pâté and liver sauce, and 3) liver sausage or pâté 
and liver patties.
The effect of eating frequency on the probability 
that a tolerable level of retinoid intake is 
exceeded when eating two certain liver foods 
is shown in Appendices 3-5. Table 19 shows the 
safe eating frequency combinations for the use 
of two liver products when the probability that 
the upper limit of retinoid intake is exceeded is 
below 1%. 
Eating liver sausage or pâté once a week seems 
to be safe in relation to retinoid intake in all 
studied age groups if main liver courses are 
eaten more seldom than they can be eaten as 
only liver food. However, an exception is the pair 
liver sausage or pâté and liver sauce with 3-year-
olds. To eliminate the risk of excessive retinoid 
intake, 3-year-olds can eat liver sausage or pâté 
only once every two week and liver sauce at 
the maximum once every two months. Another 
exception is the pair liver sausage or pâté and 
liver casserole among 1-year-olds. Because of 
smaller portion sizes and lower retinoid intakes 
from other sources as also seen above, 1-year-
olds can eat liver sausage or pâté safely every 
second day too if liver casserole is consumed 
at the maximum once every two weeks. In all 
age groups, the use of main liver courses can be 
allowed more often if the eating frequency of 
liver sausage or pâté is decreased. 
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Table 18. Safe eating frequencies when one liver product is consumed. Upper limits of liver food 
portion sizes are at most the maximum portion sizes appearing in the DIPP Nutrition Study and 
the probability, that the upper limit of retinoid intake1 is exceeded, is <1%.
Age/Product
Upper limit of liver food 
portion size (g) Safe eating frequency 
1 year
Liver sausage and pâté 30 Every second day
Liver casserole 180 Once a week
3 years
Liver sausage and pâté 70 Once a week
Liver casserole 300 Once every two weeks
Liver sauce 150 Once every two months
Liver patties 50 Once a month
6 years 
Liver sausage and pâté 80 Once a week
Liver casserole 450 Once every two weeks
Liver sauce 150 Once a month
Liver patties 50 Once every two weeks
1One- and 3-year-olds 800 μg RE/day, 6-year olds 1100 μg RE/day (SCF 2002)
Table 19. Safe eating frequency combinations when two different liver products are consumed. 
Upper limits of liver food portion sizes are at most the maximum portion sizes appearing in the 
DIPP Nutrition Study and the probability, that the upper limit of retinoid intake1 is exceeded, is 
<1%.
Age/Product
Upper limit of  
liver food portion 
 size (g)
Safe eating  
frequency combination,  
option 1
Safe eating 
frequency combination, 
 option 2
1 year
Pair
Liver sausage and pâté 30 Every second day Once a week
Liver casserole 180 Once every two weeks Once a week
3 years
Pair
Liver sausage and pâté 70 Once a week Once a month
Liver casserole 300 Once a month Once every two weeks
Pair
Liver sausage and pâté 70 Once every two weeks
Liver sauce 150 Once every two months
Pair
Liver sausage and pâté 70 Once a week Once every two weeks
Liver patties 50 Once every two months Once a month
6 years 
Pair
Liver sausage and pâté 80 Once a week Once every two weeks
Liver casserole 450 Once a month Once every two weeks
Pair
Liver sausage and pâté 80 Once a week Once every two weeks
Liver sauce 150 Once every two months Once a month
Pair
Liver sausage and pâté 80 Once a week
Liver patties 50 Once a month
1One- and 3-year-olds 800 μg RE/day, 6-year olds 1100 μg RE/day (SCF 2002)
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6. Discussion
Risk assessment
When considering the results of this risk 
assessment, it has to be noted that they have 
been produced by simulations with uncertainties 
and hypotheses. The results should be reviewed 
in concurrence with the assumptions of the 
model. For instance, retinoid distribution of 
liver foods used to estimate long term retinoid 
exposure by liver consumption relates exactly for 
a certain batch of a certain product. People may 
also switch between different products and also 
products may show variation from batch to batch 
in retinoid content, which may overestimate the 
range of possible exposures. Because the upper 
end of retinoid content is, however, the most 
important, in this assessment the safety margin 
is mainly increased by a slight overestimation of 
retinoid intake. This overestimation is dependent 
on, for instance, the batch size (amount of liver) 
applied for a certain product (not much is known 
on this), the duration of a production batch 
available for consumption by one consumer, 
size of the liver used in a batch, the variation in 
sources of liver and feeds used in the farming of 
animals used as liver sources.
Intake of vitamin A (retinoids) from liver 
foods
A percentage of Finnish children appeared to 
consume liver, but there was differences in 
apparent popularity and frequency of liver 
consumption. During the 3-day nutrition study 
period, 12 (1.2%), 150 (18.0%) and 155 (18.2%) 
of 1-, 3- and 6-year-old children, respectively, 
reported liver consumption. In all age groups, the 
most commonly used liver food was liver sausage 
or pâté, followed by liver casserole. Only a few 
of the 1-year-olds had consumed any liver foods 
during the 3-day food record period. None of the 
1-year-olds and only a few of the 3- and 6-year-
olds had consumed liver sauce or liver patties. 
When considering the total daily vitamin A 
intake from the nutritional point of view, liver 
consumption has a positive effect. Without liver 
foods, 41%, 9% and 11% of 1-, 3- and 6-year-old 
children, respectively, had vitamin A intake below 
the estimated average requirement. With liver 
foods, the average requirement was achieved by 
everyone indicating that liver consumption has 
a positive value as one of the sources of vitamin 
A. It should be noted, however, that by using 
batch related concentration of liver products, we 
may actually overestimate the proportion below 
the average requirements in the DIPP Nutrition 
Study. 
True liver eaters
The weakness of the consumption data was 
that it didn’t include any information about the 
proportion of liver eaters and non-liver eaters in 
the real population. Therefore, we did not present 
any population estimates for Finnish children. 
The results are actually valid only for the DIPP 
study population and the estimated retinoid 
exposure is conditional on the liver consumption 
frequencies and portion sizes of that study. 
One way to improve the accuracy of exposure 
estimation in a real population, is to extend 
the study period so that it is appropriate for 
the estimation of foods consumed rarely and to 
include avoidance questions in the questionnaire. 
Although exposure from single portions may be 
more important when rarely consumed foods 
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are considered, long term exposure is limited 
by frequency itself. This of course applies only 
to those toxic materials that do not accumulate 
in the body.  
Only the 3-day food records for each respondent 
caused the bias for the estimation of food 
consumption frequency of liver products which 
may be used more rarely than once per three 
days. Therefore, no reliable calculations could 
be done directly to estimate the general intake 
of vitamin A (retinoids) from liver among liver 
eaters, and estimated liver consumption reflects 
only those three-day periods when at least one 
liver food is eaten which overestimates long term 
retinoid intake. If the goal is to study exposure 
by a certain food group, one needs population 
estimates from other sources and the correlation 
with the intake of the studied food source. Portion 
size and eating frequency needs to be calibrated 
for the relevant range but are usually not needed 
to estimate for the studied source. Therefore, 
most concerns for nutritional risk assessment 
studies should be concentrated on estimation 
of general exposure: identification of at risk 
foods and consumer groups, concentrations of at 
risk food groups and clustering of consumption 
patterns.
To gain a more realistic understanding of real 
consumption of liver foods, eating frequency 
among true eaters and the proportion of true non-
eaters was estimated by zero-inflated poisson 
regression. The model itself is heavily loaded 
with assumptions as each product is modelled as 
an independent process so that the consumption 
of liver sausage or pâté did not influence the 
estimates of liver casserole and within each 
product type liver is consumed independently on 
different days. As a result, slightly over 20% of 3- 
and 6-year-old DIPP Nutrition Study children were 
estimated to be true liver sausage or pâté eaters, 
and about 40% true liver casserole eaters. These 
percentages are much higher than could be seen 
on the basis of 3-day food records. True eating 
frequencies were estimated to be every fourth 
or fifth day and every second week for liver 
sausage or pâté and liver casserole respectively, 
indicating much lower eating frequencies than 
could be estimated directly according to 3-day 
observations. 
 
Safe use of liver foods
The simulated daily retinoid intakes were 
compared with the upper limits set by the 
Scientific Committee (SCF 2002). For long term 
daily intake, a maximum intake of 800 µg RE/
d was used for 1- and 3-year-old children and 
1100 µg RE/d for 6-year-old children. Fifteen 
(15%), thirty-four (34%) and twenty-eight 
(28%) percent of 1-, 3- and 6-year-old liver 
eaters respectively, exceeded the recommended 
upper intake limit. Among non-liver eaters, there 
was no risk of exceeding the maximum intake 
level. When retinoid intakes from single liver 
meals were reviewed, liver eating didn’t lead to 
retinoid intake above the specified safe level of 
30 000 µg RE. For long term daily intake, results 
indicate that there may be also other relevant 
retinoid sources, such as fortified foods and food 
supplements, which should be restricted in order 
to avoid the possibility of exceeding the upper 
intake limit.
Safe eating frequencies were estimated for 
the portion ranges that appeared in the DIPP 
Nutrition Study for each liver food and age group. 
The estimates were done for situations where 
one or two liver foods were consumed. Because 
liver casserole, sauce and patties are usually 
eaten as main course and liver sausage or pâté 
as accompaniment, liver sausage or pâté was 
considered with each main course. In general, 
independent of age group (1-, 3- or 6-year olds), 
safety thresholds are not likely to be exceeded 
if liver sausage or pâté is eaten in moderate 
amounts once a week. At the same time only 
one of  the main liver courses can be eaten at 
the safe eating frequency varying from once a 
month to once every two months depending on 
the liver food.  
Recommendations
In order to prevent excessive intake of vitamin A, 
liver-based foods have not been recommended 
for children under the age of one year since 1990. 
For toddlers, it has been advised to restrict the 
consumption of liver-based foods (ground liver 
patties, liver steak, liver stew, and liver casserole), 
liver sausage and liver pâté to a couple of meals 
per month. This risk assessment shows that the 
restriction of children’s consumption of liver foods 
is still necessary, but the recommendations can 
be eased as compared to those given in 1990.
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7. Conclusions
This risk assessment showed that long term liver 
consumption may expose children to retinoid 
intakes higher than what is considered safe. 
The amount of vitamin A obtained from liver-
based retinoids, seems to remain below the safe 
intake from a single portion.  With long term 
consumption of liver foods however, there is a 
risk of exceeding upper tolerable intake levels. 
However, in long term consumption moderate 
portions of liver foods are still safe as long as they 
are not consumed too often. The safe portion size 
and eating frequency depend on the age group 
and type of liver food. When considering the 
total daily vitamin A intake from the nutritional 
point of view, liver consumption has a positive 
effect. However, the benefits of eating liver 
can probably be substituted by a well-balanced 
diet with plenty of vegetables and a reasonable 
amount of meat without the risk of an excess 
intake of retinoids.
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Appendix 3. Effect of eating frequency on the probability that the upper limit of retinoid intake              
is exceeded among 1-, 3- and 6-year-olds when both liver sausage or pâté and liver casserole are 
consumed at most with the maximum portion sizes appearing in the DIPP Nutrition Study and when 
retinoid exposure from both liver and non-liver sources is taken into account. The grey area represents 
a combination which does not exceed 1% probability for exceeding the upper limit of retinoid intake. 
Upper limits of retinoid intake are 800 µg RE/day for 1- and 3-year-olds and 1 100 µg RE/day for 6-
year-olds.
A) One-year-olds. Upper limit of liver sausage or pâté portion size is 30 g and that of liver casserole 
180 g.
Eating 
frequency of 
liver sausage 
or pâté
Probability (%) that upper limit of retinoid intake is exceeded when 
eating liver casserole 
Every 
day
Every 
second 
day
Every 
third 
day
Once a 
week
Once 
every 
two 
weeks
Once a 
month
Once 
every 
two 
months
Every day 91.9 81.7 71.3 41.1 26.5 20.2 17.5
Every second 
day 84.3 66.1 47.4 5.7 0.5 0.1 0
Every third day 80.9 60.5 37.2 1.2 0.1 0 0
Once a week 78.7 52.3 27.2 0.1 0 0 0
Once every two 
weeks 76.9 49.9 24.2 0.1 0 0 0
Once a month 75.6 49.2 23.7 0.1 0 0 0
Once every two 
months 75.1 49.9 21.9 0 0 0 0
Eating 
frequency of 
liver sausage 
or  pâté
Probability (%) that upper limit of retinoid intake is exceeded when 
eating liver casserole 
Every 
day
Every 
second 
day
Every 
third 
day
Once a 
week
Once 
every 
two 
weeks
Once a 
month
Once 
every 
two 
months
Every day 98.5 97.0 95.0 86.8 79.2 73.8 71.6
Every second 
day 96.8 92.8 88.4 71.8 55.3 44.7 42.2
Every third day 95.1 89.1 82.1 58.6 33.9 21.0 15.7
Once a week 91.2 81.4 72.3 32.0 4.8 0.8 0.4
Once every two 
weeks 90.7 78.2 67.3 23.1 1.6 0.1 0.1
Once a month 89.6 77.2 64.4 18.3 0.8 0.1 0
Once every two 
months 89.1 76.4 63.2 16.4 0.5 0 0
B) Three-year-olds. Upper limit of liver sausage or pâté portion size is 70 g and that of liver casserole 
300 g.
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Eating 
frequency of 
liver sausage 
or  pâté
Probability (%) that upper limit of retinoid intake is exceeded when 
eating liver casserole
Every 
day
Every 
second 
day
Every 
third 
day
Once a 
week
Once 
every 
two 
weeks
Once a 
month
Once 
every 
two 
months
Every day 98.3 96.1 94.9 86.9 76.7 70.1 67.0
Every second 
day 96.8 92.0 86.6 68.5 47.9 35.0 29.2
Every third day 94.5 88.3 81.3 54.6 25.1 10.5 6.3
Once a week 91.0 82.1 72.7 32.9 3.3 0.2 0.1
Once every 
two weeks 90.8 79.8 68.3 24.5 0.9 0.1 0
Once a month 89.9 77.7 67.3 21.2 0.4 0 0
Once every 
two months 88.5 77.9 65.1 19.6 0.5 0 0
C) Six-year-olds. Upper limit of liver sausage or pâté portion size is 80 g and that of liver casserole 
450 g.
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Appendix 4. Effect of eating frequency on the probability that the upper limit of retinoid intake is 
exceeded among 3- and 6-year-olds when both liver sausage or pâté and liver sauce are consumed at 
most with the maximum portion sizes appearing in the DIPP Nutrition Study and when retinoid exposure 
from both liver and non-liver sources is taken into account. The grey area represents a combination 
which does not exceed 1% probability for exceeding the upper limit of retinoid intake. Upper limits of 
retinoid intake are 800 µg RE/day for 1- and 3-year-olds and 1 100 µg RE/day for 6-year-olds.
A) Three-year-olds. Upper limit of liver sausage or pâté portion size is 70 g and that of liver sauce 
150 g.
Eating 
frequency of 
liver sausage 
or  pâté
Probability (%) that upper limit of retinoid intake is exceeded when 
eating liver sauce
Every 
day
Every 
second 
day
Every 
third 
day
Once a 
Week
Once 
every 
two 
weeks
Once a 
month
Once 
every 
two 
months
Every day 100 100 99.8 97.4 89.6 79.6 74.4
Every second 
day 100 100 99.8 93.2 75.0 57.0 46.1
Every third day 100 100 99.6 89.2 63.8 34.3 22.2
Once a week 100 99.9 98.9 76.8 33.5 6.4 1.1
Once every 
two weeks 100 99.9 98.3 70.2 25.4 2.6 0.4
Once a month 100 99.8 97.6 66.6 20.2 2.5 0.1
Once every 
two months 100 99.8 97.5 63.7 18.4 2.0 0.2
Eating 
frequency of 
liver sausage 
or  pâté
Probability (%) that upper limit of retinoid intake is exceeded when 
eating liver sauce
Every 
day
Every 
second 
day
Every 
third 
day
Once a 
Week
Once 
every 
two 
weeks
Once a 
month
Once 
every 
two 
months
Every day 100 100 99.5 94.3 83.0 72.6 68.2
Every second 
day 100 99.8 98.7 84.2 60.3 39.6 32.6
Every third day 100 99.7 97.8 74.2 40.4 16.4 8.3
Once a week 100 99.1 94.5 55.9 15.0 1.1 0.3
Once every two 
weeks 100 98.6 92.2 45.2 9.3 0.4 0
Once a month 100 98.4 89.9 41.0 7.4 0.4 0
Once every two 
months 100 98.4 89.5 38.4 6.7 0.4 0
B) Six-year-olds. Upper limit of liver sausage or pâté portion size is 80 g and that of liver sauce 
150 g.
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Appendix 5. Effect of eating frequency on the probability that the upper limit of retinoid intake is               
exceeded among 3- and 6-year-olds when both liver sausage or pâté and liver patties are consumed at 
most with the maximum portion sizes appearing in the DIPP Nutrition Study and when retinoid exposu-
re from both liver and non-liver sources are taken into account. The grey area represents a combination 
which does not exceed 1% probability for exceeding the upper limit of retinoid intake. Upper limits of 
retinoid intake are 800 µg RE/day for 1- and 3-year-olds and 1 100 µg RE/day for 6-year-olds.
A) Three-year-olds. Upper limit of liver sausage or pâté portion size is 70 g and that of liver patties 
50 g.
Eating 
frequency of 
liver sausage 
or  pâté
Probability (%) that upper limit of retinoid intake is exceeded when 
eating liver patties 
Every 
day
Every 
second 
day
Every 
third 
day
Once a 
week
Once 
every 
two 
weeks
Once a 
month
Once 
every 
two 
months
Every day 100 100 99.6 92.4 82.6 75.5 72.6
Every second 
day 100 99.8 98.6 83.1 63.2 49.2 42.8
Every third day 100 99.7 97.7 73.5 41.9 24.4 18.1
Once a Week 100 99.6 94.8 47.6 11.0 1.5 0.5
Once every two 
weeks 100 99.2 92.3 35.3 5.7 0.3 0.1
Once a Month 100 98.8 89.4 30.8 4.1 0.3 0
Once every two 
months 100 98.7 88.1 28.1 3.1 0.2 0
Eating 
frequency of 
liver sausage 
or  pâté
Probability (%) that upper limit of retinoid intake is exceeded when 
eating liver patties
Every 
day
Every 
second 
day
Every 
third 
day
Once a 
week
Once 
every 
two 
weeks
Once a 
month
Once 
every 
two 
months
Every day 100 99.8 98.3 86.9 76.0 68.5 66.9
Every second 
day 100 99.2 95.0 68.4 46.1 34.4 28.3
Every third day 100 98.3 90.9 49.7 22.1 9.6 5.9
Once a Week 100 96.1 81.7 21.1 3.0 0.3 0.1
Once every two 
weeks 99.9 93.9 75.1 15.0 1.2 0.1 0
Once a month 99.9 92.5 71.0 11.2 1.0? 0 0
Once every two 
months 99.8 92.0 67.4 10.3 1.1 0 0
B) Six-year-olds. Upper limit of liver sausage or pâté portion size is 80 g and that of liver patties 
50 g.
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